STEPAN CO
10-K, 2000-03-30
SOAP, DETERGENTS, CLEANG PREPARATIONS, PERFUMES, COSMETICS
Previous: STEPAN CO, DEF 14A, 2000-03-30
Next: STOCKER & YALE INC, 10KSB, 2000-03-30



<PAGE>

- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
                                 UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549
                               ----------------
                                   FORM 10-K
(Mark
One)

  [X]            ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
                    OF THE SECURITIES EXCHANGE ACT OF 1934
                  For the fiscal year ended December 31, 1999
                                      OR
  [_]      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                        SECURITIES EXCHANGE ACT OF 1934
                For the transition period from        to
                         Commission File Number 1-4462
                               ----------------
                                STEPAN COMPANY
            (Exact name of registrant as specified in its charter)
<TABLE>
<S>                                       <C>
                Delaware                        36-1823834
    (State or other jurisdiction of          (I.R.S. Employer
     incorporation or organization)       Identification Number)
        Edens and Winnetka Road,                  60093
          Northfield, Illinois                  (Zip Code)
(Address of principal executive offices)
</TABLE>
        Registrant's telephone number including area code: 847-446-7500
         Securities registered pursuant to Section 12 (b) of the Act:
<TABLE>
<CAPTION>
                                                       Name of Each Exchange
                  Title of Each Class                   on Which Registered
                  -------------------                  ---------------------
      <S>                                             <C>
      Common Stock, $1 par value                      New York Stock Exchange
                                                      Chicago Stock Exchange
      5 1/2% Convertible Preferred Stock, no par      New York Stock Exchange
       value                                          Chicago Stock Exchange
</TABLE>
         Securities registered pursuant to Section 12 (g) of the Act:
                                     None
                               (Title of Class)
   Indicate by check mark if disclosure of delinquent filers pursuant to Item
405 of Regulation S-K is not contained herein, and will not be contained, to
the best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in part III of this Form 10-K or any
amendment to this Form 10-K. [ ].
   Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of
1934 during the preceding 12 months, and (2) has been subject to such filing
requirements for the past 90 days. Yes  X   No
   Aggregate market value at February 29, 2000, of voting stock held by
nonaffiliates of the registrant: $128,040,000*
   Number of shares outstanding of each of the issuer's classes of common
stock as of February 29, 2000:
<TABLE>
<CAPTION>
                Class                         Outstanding at February 29, 2000
                -----                         --------------------------------
      <S>                                     <C>
      Common Stock, $1 par value                         9,516,863
</TABLE>
                      Documents Incorporated by Reference
<TABLE>
<CAPTION>
        Part of Form 10-K                        Document Incorporated
        -----------------                        ---------------------
      <S>                                 <C>
      Part I, Item 1                      1999 Annual Report to Stockholders
      Part II, Items 5-8                  1999 Annual Report to Stockholders
      Part III, Items 10-12               Proxy Statement dated March 30, 2000
</TABLE>
   *Based on reported ownership by all directors, officers and beneficial
owners of more than 5% of registrant's voting stock. However, this
determination does not constitute an admission of affiliate status for any of
these holders.

- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
<PAGE>

                                    PART I

Item 1. Business

   Stepan Company and its subsidiaries (the "company") produce specialty and
intermediate chemicals which are sold to other manufacturers and then made
into a variety of end products. The company has three reportable segments:
surfactants, polymers and specialty products. Surfactants refer to chemical
agents which affect the interaction between two surfaces; they can provide
actions such as detergency (i.e., the ability of water to remove soil from
another surface), wetting and foaming, dispersing, emulsification (aiding two
dissimilar liquids to mix), demulsification and viscosity modifications.
Surfactants are the basic cleaning agent in detergents for washing clothes,
dishes, carpets, fine fabrics, floors and walls. Surfactants are also used for
the same purpose in shampoos and conditioners, toothpastes, cosmetics and
other personal care products. Commercial and industrial applications include
emulsifiers for agricultural products, emulsion polymers such as floor
polishes and latex foams and coatings, wetting and foaming agents for
wallboard manufacturing and surfactants for enhanced oil recovery. Polymers
derives its revenue from the sale of phthalic anhydride, polyols and
polyurethane foam systems used in plastics, building materials and
refrigeration industries. Specialty products sells chemicals used in food,
flavoring and pharmaceutical applications.

MARKETING AND COMPETITION

   Principal markets for surfactants are manufacturers of detergents,
shampoos, lotions, toothpastes and cosmetics. Surfactants are also sold to the
producers of emulsifiers and lubricating products. The company also is a
principal provider of polymers used in construction, refrigeration,
automotive, boating and other consumer product industries. Specialty products
are used primarily by food and pharmaceutical manufacturers.

   The company does not sell directly to the retail market, but sells to a
wide range of manufacturers in many industries and has many competitors. The
principal methods of competition are product performance, price and
adaptability to the specific needs of individual customers. These factors
allow the company to compete on a basis other than solely price, reducing the
severity of competition as experienced in the sales of commodity chemicals
having identical performance characteristics. The company is a leading
merchant producer of surfactants in the United States. In the case of
surfactants, much of the company's competition comes from the internal
divisions of larger companies, as well as several large national and regional
producers. In the manufacture of polymers, the company competes with the
chemical divisions of several large companies, as well as with other small
specialty chemical manufacturers. In recent years, the company has also faced
periodic competition from foreign imports of phthalic anhydride. In specialty
products, the company competes with several large firms plus numerous small
companies. The company does not expect any significant changes in the
competitive environment in the foreseeable future.

MAJOR CUSTOMER AND BACKLOG

   The company does not have any one single customer whose business represents
more than 10 percent of the company's consolidated revenue. Most of the
company's business is essentially on the "spot delivery basis" and does not
involve a significant backlog. The company does have some contract
arrangements with certain customers, but purchases are generally contingent on
purchaser requirements.

ENERGY SOURCES

   Substantially all of the company's manufacturing plants operate on
electricity and interruptable gas purchased from local utilities. During peak
heating demand periods, gas service to all plants may be temporarily
interrupted for varying periods ranging from a few days to several months. The
plants operate on fuel oil during these gas interruption periods. The company
has not experienced any plant shutdowns or adverse effects upon its business
in recent years that were caused by a lack of available energy sources.

                                       1
<PAGE>

RAW MATERIALS

   The most important raw materials used by the company are of a petroleum or
vegetable nature. For 2000, the company has commitments from suppliers to
cover its forecasted requirements and is not substantially dependent upon any
one supplier.

RESEARCH AND DEVELOPMENT

   The company maintains an active research and development program to assist
in the discovery and commercialization of new knowledge with the intent that
such effort will be useful in developing a new product or in bringing about a
significant improvement to an existing product or process. Total expenses for
research and development during 1999, 1998 and 1997 were $13,113,000,
$12,219,000, and $12,404,000, respectively. The balance of expenses reflected
on the Consolidated Statements of Income relates to technical services which
include routine product testing, quality control and sales support service.

ENVIRONMENTAL COMPLIANCE

   Compliance with applicable federal, state and local regulations regarding
the discharge of materials into the environment, or otherwise relating to the
protection of the environment, resulted in capital expenditures by the company
of approximately $2,740,000 during 1999 and should approximate that amount in
2000. These expenditures represented approximately eight percent of the
company's capital expenditures in 1999 and are expected to be approximately
seven percent of such expenditures in 2000. These expenditures, when incurred,
are depreciated and charged on a straight-line basis to pre-tax earnings over
their respective useful lives which are typically 10 years. Compliance with
such regulations is not expected to have a material adverse effect on the
company's earnings and competitive position in the foreseeable future.

EMPLOYMENT

   At December 31, 1999 and 1998, the company employed worldwide 1,365 and
1,372 persons, respectively.

FOREIGN OPERATIONS

   See Note 14, Segment Reporting, on page 33 of the company's 1999 Annual
Report to Stockholders.

SEGMENTS

   See Note 14, Segment Reporting, on page 33 of the company's 1999 Annual
Report to Stockholders.

Item 2. Properties

   The company's corporate headquarters and central research laboratories are
located in Northfield, Illinois. The Northfield facilities contain
approximately 70,000 square feet on an eight acre site. In addition, the
company leases 49,000 square feet of office space in a nearby office complex.

   Stepan Canada maintains a leased sales office in Mississagua, Canada.
Stepan Mexico maintains a leased sales office in Mexico City, Mexico.

   Surfactants are produced at four plants in the United States and five
wholly owned subsidiaries: one in France, Canada, Mexico, Colombia and
Germany. The principal plant is located on a 626 acre site at Millsdale
(Joliet), Illinois. A second plant is located on a 44 acre tract in
Fieldsboro, New Jersey. West Coast operations are conducted on an eight acre
site in Anaheim, California. A fourth plant is located on a 175 acre site in
Winder, Georgia. The plant, laboratory and office of Stepan Europe are located
on a 20 acre site near Grenoble, France. Stepan Canada, Inc. is located on a
70 acre leased, with an option to purchase, site in Longford Mills, Ontario,
Canada. Stepan Mexico is located on a 13 acre site in Matamoros, Mexico.
Stepan Germany is located on a five

                                       2
<PAGE>

acre site in Cologne, Germany. Stepan Colombia is located on a five acre site
in Manizales, Colombia. The phthalic anhydride, polyurethane systems and
polyurethane polyols plants are also located at Millsdale. Specialty products
are mainly produced at a plant located on a 19 acre site in Maywood, New
Jersey.

   The company owns all of the foregoing facilities except the leased office
space and Canadian plant site mentioned above. The company believes these
properties are adequate for its operations.

Item 3. Legal Proceedings

   As reported previously, on October 21, 1999, the company reached an
agreement in principle to settle an action entitled Gilberg v. Stepan et al.,
now known as Accurso v. Stepan et al. (L-1064-98-MT; Case Code No. 242)
alleging possible personal injuries related to environmental claims in New
Jersey. Final settlement of this action occurred, as scheduled, on December 1,
1999. All terms of the settlement are confidential pursuant to a court order.
As previously reported, as a result of this settlement, the company recorded a
third quarter $6.3 million after-tax charge to earnings.

   As reported previously, the company has been named as a potentially
responsible party (PRP) in the case USEPA v. Jerome Lightman (92 CV 4710)
(JBS) which involves the Ewan and D'Imperio Superfund Sites located in New
Jersey. Trial on the issue of the company's liability at these sites is
expected to be completed in March 2000. Should the company lose, there would
then be a trial as to the company's allocated share of clean-up costs at these
sites. This latter trial would occur, if at all, in fiscal 2000. The company
believes it has adequate defenses to the issue of liability. In the event of
an unfavorable outcome related to the liability, the company believes it has
adequate reserves. On a related matter, the company has filed an appeal to the
United States Third Circuit Court of Appeals objecting to the lodging of a
partial consent decree in favor of the United States Government in this
action. Under the partial consent decree, the government recovered past costs
at the site from all PRPs including the company. The company paid its assessed
share but by objecting to the partial consent decree, the company is seeking
to recover back the sums it paid.

   As reported previously, the company's site in Maywood, New Jersey and
property formerly owned by the company adjacent to its current site, were
listed on the National Priorities List in September 1993 pursuant to the
provisions of the Comprehensive Environmental Response Compensation and
Liabilities Act because of certain alleged chemical contamination. Pursuant to
an Administrative Order on Consent entered into between the United States
Environmental Protection Agency (USEPA) and the company for property formerly
owned by the company, and the issuance of an order by the USEPA to the company
for property currently owned by the company, the company has completed a
Remedial Investigation Feasibility Study in 1994. The company has been
awaiting the issuance of a Record of Decision (ROD) from the USEPA which would
relate to both the currently owned and formerly owned company property and
would recommend the type of remediation required on each property. The company
does not know when the ROD will be issued by the USEPA.

   In 1985, the company entered into a Cooperative Agreement with the United
States of America represented by the Department of Energy (Agreement).
Pursuant to this Agreement, the Department of Energy took title to
radiological contaminated materials and was to remediate, at its expense, all
radiological (byproduct material and source material) waste on the company's
property in Maywood, New Jersey. The Maywood property (and portions of the
surrounding area) were remediated by the Department of Energy under the
Formerly Utilized Sites Remedial Action Program, a federal program under which
the U.S. Government undertook to remediate properties which were used to
process radiological material for the U.S. Government. In 1997, responsibility
for this clean-up was transferred to the United States Army Corps of Engineers
(USACE). On January 29, 1999, the company received a copy of the USACE Report
to Congress dated January 1998 in which the USACE first expressed their
intention to evaluate, with the USEPA, whether the company and/or other
parties might be responsible for cost recovery or contribution claims related
to the Maywood site. Since that report has been issued by the USACE, the USACE
has requested legal advice from the Department of Justice as to the
interpretation of the Cooperative Agreement. There has been no report issued
by the Department of Justice as of this date. Based upon the company's
agreement with the United States of America, it is the company's belief that
its liability, if any, has been resolved with regard to the United States of
America.


                                       3
<PAGE>

   Reference is made to the Casmalia Disposal Site located in Santa Barbara
County, California. The company has settled its de minimis liability at this
site with no material impact on the financial condition of the company.

   On December 13, 1999, the company was served in an action entitled
Pennsauken Solid Waste Management Authority v. State of New Jersey, et al. The
company filed its answer to this action. It appears that although the company
was named as a party, there are no allegations regarding dates of hauling or
amounts. The company does not believe its liability, if any, will have a
material impact on the financial condition of the company.

   As to the following sites:

- --ABC Barrel & Drum Co. -- Detroit, Michigan
- --Batavia Landfill -- Batavia, New York
- --Bofors Nobel Site -- Muskegon, Michigan
- --Chemsol, Inc. -- Piscataway, New Jersey
- --Chem-Trol Pollution Services, Inc. -- Hamburg, New York
- --Delilah Road Site -- Atlantic County, New Jersey
- --Gallup's Quarry -- Plainfield, Connecticut
- --Iron Horse Park/Shaffer Landfill -- Billerica, Massachusetts
- --Memphis Container aka Tri-State Drums -- Memphis, Shelby County, Tennessee
- --Nyanza Chemical Waste Dump -- Ashland, Massachusetts
- --Twin Cities -- Arvada, Colorado
- --Virginia RR Washout,

all of which have been previously reported, there has been no further activity
or inquiry since the first notice.

   Reference is made to the suit Olin Corporation v. Fisons plc et al. (93-
11166-MLW). The company was dismissed from this action by the federal court
with the right of Nor-Am, one of the defendants, to file a Motion for
Reconsideration. Nor-Am filed a Motion for Reconsideration of the company's
dismissal on June 28, 1999. Based on a notation on the federal court's docket
sheet, the company believes that the court denied Nor-Am's Motion for
Reconsideration on February 9, 2000. The company believes its liability at
this site has been fully resolved.

   On February 10, 2000, the company was served with an Administrative
Complaint filed by Region 5 of the United States Environmental Protection
Agency (FIFRA-5-2000-011) alleging violations of the Federal Insecticide,
Fungicide and Rodenticide Act. The total proposed penalty is $141,000. The
company has until April 4, 2000, to file a responsive answer in this matter.
The company is currently investigating these allegations and therefore, cannot
predict what its liability, if any, will be in this case.

Item 4. Results of Votes of Security Holders

   No matters were submitted to stockholders during the fourth quarter of the
fiscal year ended December 31, 1999.

Executive Officers of the Registrant

   Executive Officers are elected annually by the Board of Directors at the
first meeting following the Annual Meeting of Stockholders to serve until the
next annual meeting of the Board and until their respective successors are
duly elected and qualified.

   Effective February 15, 1999, F. Quinn Stepan, Jr., was elected President
and Chief Operating Officer. He was previously Vice President and General
Manager--Surfactants as of January 1, 1997, Vice President--Global Laundry and
Cleaning Products as of May 1996 and Director--Business Management as of May
1992. Mr. F. Quinn Stepan, Sr., who has served the company as Chairman and
Chief Executive Officer since 1984 and as President since 1973, remains
Chairman and Chief Executive Officer.

                                       4
<PAGE>

   Effective February 16, 1999, John V. Venegoni was appointed Vice President
and General Manager--Surfactants. Since May 1992 until May 1996, he served as
a Senior Business Manager--Consumer Products. From May 1996, until February
16, 1999, he was Director--Global Personal Care.

   Effective May 22, 1995, Jeffrey W. Bartlett, formerly Vice President,
General Counsel and Corporate Secretary, was appointed Vice President, General
Counsel, Regulatory Affairs and Corporate Secretary* (see below). Effective
January 1, 1995, James A. Hartlage, who was formerly the Senior Vice
President--Technology, was appointed Senior Vice President--Technology and
Operations. In addition, during 1995 he assumed Administrative
responsibilities. Effective January 1, 1995, Earl H. Wagener, formerly Vice
President--Product Development, was appointed Vice President--Research and
Development. All other executive officers have remained in their current
capacity for over five years.

   The Executive Officers of the company, their ages as of February 29, 2000,
and certain other information are as follows:

<TABLE>
<CAPTION>
                                                                  Year First
           Name           Age              Title                Elected Officer
           ----           ---              -----                ---------------
 <C>                      <C> <S>                               <C>
 F. Quinn Stepan......... 62  Chairman and Chief Executive           1967
                              Officer
 F. Quinn Stepan, Jr. ... 39  President and Chief Operating          1997
                              Officer
 James A. Hartlage....... 62  Senior Vice President--                1980
                              Technology and Operations
 Ronald L. Siemon........ 62  Vice President and General             1992
                              Manager--Polymers
 Jeffrey W. Bartlett*.... 56  Vice President, General                1983
                              Counsel, Regulatory Affairs and
                              Corporate Secretary
 Walter J. Klein......... 53  Vice President--Finance                1985
 Mickey Mirghanbari...... 62  Vice President--Manufacturing          1992
                              and Engineering
 Earl H. Wagener......... 59  Vice President--Research and           1995
                              Development
 John V. Venegoni........ 41  Vice President and General             1999
                              Manager--Surfactants
</TABLE>

*Jeffrey W. Bartlett passed away on March 21, 2000.

                                    PART II

Item 5. Market for Registrant's Common Stock and Related Security Holder
Matters

   (a) The company's common stock is listed and traded on both the New York
Stock Exchange and the Chicago Stock Exchange. See page 35 of the company's
1999 Annual Report to Stockholders for market price information which is
incorporated by reference herein.

   The company's 5 1/2 percent convertible preferred stock is listed and
traded on the New York Stock Exchange and the Chicago Stock Exchange. See Note
7 on page 29 of the company's 1999 Annual Report to Stockholders for the
description of the preferred stockholders' rights which is incorporated by
reference herein.

   From time to time the company purchases shares of its common stock in the
open market and in block transactions from dealers for the purpose of funding
option grants under its stock option plans and deferred compensation plans for
directors and officers.

   (b) On February 29, 2000, there were 1,423 holders of common stock of the
company.

   (c) See page 35 of the company's 1999 Annual Report to Stockholders for
dividend information which is incorporated by reference herein. Also see Note
4 on page 28 of the company's 1999 Annual Report to Stockholders which sets
forth the restrictive covenants covering dividends.

Item 6. Selected Financial Data

   See page 35 of the company's 1999 Annual Report to Stockholders for a five
year summary of selected financial information which is incorporated by
reference herein.

                                       5
<PAGE>

Item 7. Management's Discussion and Analysis of Financial Condition and
      Results of Operations and Quantitative and Qualitative Disclosures about
      Market Risk

   See pages 14 through 19 of the company's 1999 Annual Report to Stockholders
which is incorporated by reference herein.

   Some information contained in the Management's Discussion and Analysis is
forward looking and involves risks and uncertainties. The results achieved
this year are not necessarily an indication of future prospects for the
company. Actual results in future years may differ materially. Potential risks
and uncertainties include, among others, fluctuations in the volume and timing
of product orders, changes in demand for the company's products, changes in
technology, continued competitive pressures in the marketplace, availability
of raw materials, foreign currency fluctuations and general economic
conditions.

Item 8. Financial Statements and Supplementary Data

   See pages 20 through 34 of the company's 1999 Annual Report to Stockholders
for the company's consolidated financial statements, notes to the consolidated
financial statements and auditors' report which are incorporated by reference
herein.

   See page 35 of the company's 1999 Annual Report to Stockholders for
selected quarterly financial data which is incorporated by reference herein.

Item 9. Disagreements on Accounting and Financial Disclosure

   None

                                   PART III

Item 10. Directors and Executive Officers of the Registrant

   (a) Directors

   Mr. Paul Stepan is a general partner of a partnership having an interest in
certain real estate which is unrelated to the business of the company. The
partnership of which Mr. Paul Stepan is a general partner, filed in bankruptcy
for Chapter 11 protection in February, 1998. Mr. Paul Stepan advised that a
refinancing package and successful discharge from Chapter 11 occurred.

   For additional information about the company's Directors, see pages 3
through 5 of the company's Proxy Statement dated March 30, 2000, for the
Annual Meeting of Stockholders which are incorporated by reference herein.

   (b) Executive Officers

     See Executive Officers of the Registrant in Part I above.

Item 11. Executive Compensation

   See pages 7 and 8 of the company's Proxy Statement dated March 30, 2000,
for the Annual Meeting of the Stockholders which are incorporated by reference
herein.

Item 12. Security Ownership of Certain Beneficial Owners and Management

   See pages 1 through 6 of the company's Proxy Statement dated March 30,
2000, for the Annual Meeting of Stockholders which are incorporated by
reference herein.

                                       6
<PAGE>

Item 13. Certain Relationships and Related Transactions

   None

                                    PART IV

Item 14. Exhibits, Financial Statement Schedules and Reports on Form 8-K

   (a) & (d) Financial Statements and Schedules

     See the Index to the Consolidated Financial Statements and Supplemental
  Schedule filed herewith.

   (b) Reports on Form 8-K

     A report on Form 8-K was filed on October 22, 1999, regarding quarterly
  earnings.

   (c) Exhibits

     See Exhibit Index filed herewith.

                                       7
<PAGE>

                                  SIGNATURES

   Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.

                                          Stepan Company

                                                    /s/ Walter J. Klein
                                          By: _________________________________
                                                  Vice President--Finance

March 30, 2000

   Pursuant to the requirements of the Securities Exchange Act of 1934, this
report has been signed below by the following persons on behalf of the
Registrant and in the capacities and on the dates indicated.

<TABLE>
<S>                                    <C>                         <C>
         /s/ F. Quinn Stepan           Chairman, Chief Executive     March 30, 2000
______________________________________    Officer and Director
         F. Quinn Stepan Name

       /s/ F. Quinn Stepan, Jr.        President, Chief Operating    March 30, 2000
______________________________________    Officer and Director
         F. Quinn Stepan, Jr.

         /s/ Walter J. Klein            Vice President--Finance,     March 30, 2000
______________________________________   Principal Financial and
           Walter J. Klein                 Accounting Officer

        /s/ James A. Hartlage           Senior Vice President--      March 30, 2000
______________________________________  Technology and Operations
          James A. Hartlage                   and Director

        /s/ Thomas F. Grojean                   Director             March 30, 2000
______________________________________
          Thomas F. Grojean

          /s/ Paul H. Stepan                    Director             March 30, 2000
______________________________________
            Paul H. Stepan

        /s/ Robert D. Cadieux                   Director             March 30, 2000
______________________________________
          Robert D. Cadieux

         /s/ Robert G. Potter                   Director             March 30, 2000
______________________________________
           Robert G. Potter
</TABLE>

   Walter J. Klein, pursuant to powers of attorney executed by each of the
directors and officers listed above, does hereby execute this report on behalf
of each of such directors and officers in the capacity in which the name of
each appears above.

                                          Walter J. Klein
March 30, 2000

                                       8
<PAGE>

                                 INDEX TO THE
                       CONSOLIDATED FINANCIAL STATEMENTS
                                      AND
                             SUPPLEMENTAL SCHEDULE

   A copy of Stepan Company's Annual Report to Stockholders for the year ended
December 31, 1999, has been filed as an exhibit to this Annual Report on Form
10-K. Pages 20 through 34 of such Annual Report to Stockholders contain the
Consolidated Balance Sheets as of December 31, 1999 and 1998, the Consolidated
Statements of Income, Stockholders' Equity and Cash Flows and Notes to
Consolidated Financial Statements for the three years ended December 31, 1999,
1998 and 1997, and the Auditors' Report covering the aforementioned financial
statements. These consolidated financial statements and the Auditors' Report
thereon are incorporated herein by reference.

   Supplemental Schedule II--Allowance for Doubtful Accounts--to Consolidated
Financial Statements, which is required to comply with regulation S-X, and the
Auditors' report on such Supplemental Schedule are included on pages 10 and 11
of this Form 10-K.

   Certain supplemental schedules are not submitted because they are not
applicable or not required, or because the required information is included in
the financial statements or notes thereto.

                                       9
<PAGE>

                                 STEPAN COMPANY

           SUPPLEMENTAL SCHEDULE TO CONSOLIDATED FINANCIAL STATEMENTS
                      FOR THE YEAR ENDED DECEMBER 31, 1999
                   AS REQUIRED TO COMPLY WITH REGULATION S-X

Schedule II--Allowance for Doubtful Accounts:

   Below is an analysis of the allowance for doubtful accounts for the three
years ended December 31:

<TABLE>
<CAPTION>
                                                          1999    1998    1997
                                                         ------  ------  ------
                                                            (In Thousands)
<S>                                                      <C>     <C>     <C>
Balance, Beginning of Year.............................. $2,263  $2,121  $2,074
  Provision charged to income...........................    222     339     548
  Accounts written off, net of recoveries...............    (96)   (197)   (501)
                                                         ------  ------  ------
Balance, End of Year.................................... $2,389  $2,263  $2,121
                                                         ======  ======  ======
</TABLE>

                                       10
<PAGE>

                   REPORT OF INDEPENDENT PUBLIC ACCOUNTANTS
                           ON SUPPLEMENTAL SCHEDULE

To Stepan Company:

   We have audited in accordance with generally accepted auditing standards,
the financial statements included in Stepan Company's Annual Report to
Stockholders incorporated by reference in this Form 10-K, and have issued our
report thereon dated February 10, 2000. Our audit was made for the purpose of
forming an opinion on those statements taken as a whole. The supplemental
schedule listed in the index of financial statements is the responsibility of
the company's management and is presented for purposes of complying with the
Securities and Exchange Commission's rules and is not part of the basic
financial statements. This schedule has been subjected to the auditing
procedures applied in the audit of the basic financial statements and, in our
opinion, fairly states in all material respects the financial data required to
be set forth therein in relation to the basic financial statements taken as a
whole.

                                          Arthur Andersen LLP

Chicago, Illinois,
February 10, 2000

                                      11
<PAGE>

                                 EXHIBIT INDEX

<TABLE>
<CAPTION>
  Exhibit
    No.                                 Description
  -------                               -----------
 <C>       <S>
 (3)a      Copy of the Certificate of Incorporation, and the Certificates of
           Amendment of Certificate of Incorporation, dated May 6, 1968, April
           20, 1972, April 16, 1973, December 2, 1983. Filed with the Company's
           Annual Report on Form 10-K for the year ended December 31, 1983, and
           incorporated herein by reference.

 (3)a(1)   Copy of Certificate of Amendment of Certificate of Incorporation,
           dated May 24, 1999. (Note 13)

 (3)b      Copy of the Bylaws of the company as amended through February 15,
           1999. (Note 14)

 (3)c      Copy of Certificate of Amendment, dated April 28, 1993, to Article
           IV of Certificate of Incorporation. (Note 7)

 (3)d      Copy of Certificate of Amendment, dated May 5, 1987, to Article X of
           Certificate of Incorporation. (Note 1)

 (4)h      Copy of Loan Agreement, dated June 15, 1995, with Aid Association
           for Lutherans, the Northwestern Mutual Life Insurance Company and
           The Mutual Life Insurance Company of New York. (Note 10)

 (4)i      Copy of Revolving Credit and Term Loan Agreement, dated February 20,
           1990, with The First National Bank of Chicago and the amendment,
           dated March 21, 1990. (Note 3)

 (4)m      Copy of Second Amendment, dated September 20, 1991, amending
           Revolving Credit and Term Loan Agreement, dated February 20, 1990
           (see (4)i above). (Note 4)

 (4)m(1)   Copy of Third Amendment, dated December 29, 1992, amending Revolving
           Credit and Term Loan Agreement, dated February 20, 1990 (see (4)i
           and (4)m above). (Note 8)

 (4)m(2)   Copy of Fourth Amendment, dated May 31, 1994, amending Revolving
           Credit and Term Loan Agreement, dated February 20, 1990 (see (4)i,
           (4)m and (4)m(1) above). (Note 9)

 (4)n(1)   Copy of Certificate of Designation, Preferences and Rights of the 5
           1/2% Convertible Preferred Stock, without Par Value and the Amended
           Certificate, dated August 12, 1992 and April 28, 1993. (Note 7)

 (4)n(2)   Copy of Issuer Tender Offer Statement on Schedule 13E-4, dated
           August 13, 1992. (Note 6)

 (4)n(3)   Copy of Amendment No. 1 to Schedule 13E-4 (see also (4)n(2) above),
           dated September 23, 1992. (Note 6)

 (4)n(4)   Copy of the company's Form 8-A, dated August 13, 1992. (Note 6)

 (4)o      Copy of Revolving Credit and Term Loan Agreement, dated January 9,
           1998, with The First National Bank of Chicago. (Note 11)

 (4)o(1)   Copy of Certificate of Amendment, dated March 12, 1999, amending
           Revolving Credit and Term Loan Agreement, dated January 9, 1998.
           (Note 12)

 (4)p      Copy of Term Loan Agreement, dated October 1, 1998, with The
           Northwestern Mutual Life Insurance Company and Connecticut General
           Life Insurance Company. (Note 14)

           In accordance with 601(b)(4) (iii) of Regulation S-K, certain debt
           instruments are omitted, where the amount of securities authorized
           under such instruments does not exceed 10% of the total consolidated
           assets of the Registrant. Copies of such instruments will be
           furnished to the Commission upon request.

 (10)a     Description of the 1965 Directors Deferred Compensation Plan. (Note
           2)

 (10)b     Copy of the 1969 Management Incentive Compensation Plan as amended
           and restated as of January 1, 1992. (Note 5)

 (10)d     Copy of the 1982 Stock Option Plan. (Note 2)

 (10)e     Copy of Leveraged Employee Stock Ownership Plan. (Note 3)
</TABLE>
<PAGE>

<TABLE>
<CAPTION>
  Exhibit
    No.                                 Description
  -------                               -----------
 <C>       <S>
 (10)f     Copy of the company's 1992 Stock Option Plan. (Note 5)

 (13)      Copy of the company's 1999 Annual Report to Stockholders.

 (18)      Letter re change in accounting principle for the year ended December
           31, 1992. (Note 8)

 (21)      Subsidiaries of Registrant at December 31, 1999.

 (23)      Consent of Independent Public Accountants.

 (24)      Power of Attorney.

 (27)      Financial Data Schedule.
</TABLE>

                             Notes To Exhibit Index

<TABLE>
<CAPTION>
 Note
 No.
 ----
 <C>  <S>
  1.  Filed with the company's Annual Report on Form 10-K for the year ended
      December 31, 1987, and incorporated herein by reference.

  2.  Filed with the company's Annual Report on Form 10-K for the year ended
      December 31, 1988, and incorporated herein by reference.

  3.  Filed with the company's Annual Report on Form 10-K for the year ended
      December 31, 1989, and incorporated herein by reference.

  4.  Filed with the company's Quarterly Report on Form 10-Q for the quarter
      ended September 30, 1991, and incorporated herein by reference.

  5.  Filed with the company's Quarterly Report on Form 10-Q for the quarter
      ended March 31, 1992, and incorporated herein by reference.

  6.  Filed with the company's Quarterly Report on Form 10-Q for the quarter
      ended September 30, 1992, and incorporated herein by reference.

  7.  Filed with the company's Current Report on Form 8-K filed on April 28,
      1993, and incorporated herein by reference.

  8.  Filed with the company's Annual Report on Form 10-K for the year ended
      December 31, 1992, and incorporated herein by reference.

  9.  Filed with the company's Annual Report on Form 10-K for the year ended
      December 31, 1994, and incorporated herein by reference.

 10.  Filed with the company's Quarterly Report on Form 10-Q for the quarter
      ended June 30, 1995, and incorporated herein by reference.

 11.  Filed with the company's Annual report on Form 10-K for the year ended
      December 31, 1997, and incorporated herein by reference.

 12.  Filed with the company's Quarterly Report on Form 10-Q for the quarter
      ended March 31, 1999, and incorporated herein by reference.

 13.  Filed with the company's Quarterly Report on Form 10-Q for the quarter
      ended June 30, 1999, and incorporated herein by reference.

 14.  Filed with the company's Annual Report on Form 10-K for the year ended
      December 31, 1998, and incorporated herein by reference.
</TABLE>

<PAGE>

                                                                      Exhibit 13

                    MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                 FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Results of Operations

1999 Compared with 1998

Net sales for 1999 increased nine percent to a record $666.8 million.  The
increase was primarily the result of an eight percent growth in sales volume.
Net sales by segment were as follows (prior year data has been reclassified to
conform to 1999 presentation):

<TABLE>
<CAPTION>
                                                                      Percent
  (Dollars in thousands)             1999             1998            Change
  ---------------------------------------------------------------------------
  <S>                              <C>              <C>               <C>
  Surfactants                      $524,956         $474,454             +11
  Polymers                          121,438          116,460              +4
  Specialty Products                 20,390           19,537              +4
                                   --------         --------
     Total                         $666,784         $610,451              +9
                                   ========         ========
</TABLE>

     Surfactants are a principal ingredient in consumer and industrial cleaning
products such as detergents, shampoos, lotions, toothpastes and cosmetics. Other
applications include lubricating ingredients and emulsifiers for spreading of
agricultural products and plastics and composites.

     Surfactants net sales, representing 79 percent of the company's revenue,
increased $50.5 million, or 11 percent, due primarily to a nine percent rise in
sales volume. Domestic and foreign operations contributed to the overall growth.
Domestic sales increased $23.7 million, or six percent, due to a six percent
gain in sales volume. Rising demand for personal care and laundry and cleaning
products was the main contributor to the improved sales volume. Exports to Asia
also experienced a solid recovery from the weakness of a year ago. Foreign
operations reported a $26.8 million, or 27 percent, increase in net sales due
largely to higher sales volume. All foreign subsidiaries posted net sales
increases. Canadian operations benefited from the fourth quarter 1998
acquisition of the anionic and cationic surfactants business from Boehme-Filatex
Canada, Inc. Mexican operations' net sales increase also was aided by a major
customer switching from consigning raw material and paying a processing fee to
buying finished products inclusive of raw materials costs. 1999 was the first
full-year consolidation of Stepan Colombia.

     The polymers product group includes phthalic anhydride (PA), polyurethane
systems and polyurethane polyols. PA is used in polyester alkyd resins and
plasticizers for applications in construction materials and components of
automotive, boating and other consumer products. Polyurethane systems provide
thermal insulation and are sold to the construction, industrial and appliance
markets. Polyurethane polyols are used in the manufacture of laminate board for
the construction industry.

     Polymers' net sales, accounting for 18 percent of the company's revenue,
increased four percent mainly due to a four percent rise in sales volume.
Globally, polyurethane polyols accounted for most of the growth with a gain in
net sales of $5.6

                                      14
<PAGE>

million, or nine percent, due to a 10 percent growth in sales volume. North
American, South American and European sales all increased between years.
Polyurethane systems reported a $1.1 million, or six percent, increase in net
sales based on improved sales volume. PA's sales volume drop of four percent,
coupled with decreased average selling prices, caused a $1.7 million, or five
percent, decline in net sales.

     Specialty products include flavors, emulsifiers and solubilizers used in
the food and pharmaceutical industry. Net sales for the year were $20.4 million,
a rise of $0.9 million, or four percent, over 1998. Increased volume and higher
average selling prices contributed to the growth.

     Gross profit increased to $120.9 million in 1999 from $111.6 million in
1998. 1999 Surfactants gross profit of $87.6 million was 11 percent higher than
a year ago. The rise was driven by a nine percent growth in sales volume.
Domestic operations reported a $5.9 million, or nine percent, increase based on
a six percent rise in sales volume. In addition, the early termination of a
sales contract resulted in the recognition of $2.7 million of income. Improved
sales volumes and margins for French and Canadian operations coupled with the
whole year consolidation of the Colombian subsidiary led to the increase in
foreign operations. The results were adversely affected by continued weakness in
the German operation. Polymers' gross profit remained unchanged at $27.8 million
between years despite record profits from domestic polyurethane polyols and
higher polyurethane systems profit. Globally, polyurethane polyols profit
increased $2.6 million, or 13 percent. Higher volumes and domestic margins
accounted for the gain. Decreased margins in Europe dampened polyurethane
polyols results. Increased volumes and margins also caused a $0.5 million, or 14
percent, profit increase for polyurethane systems. Lower PA gross profit, due to
decreased volume and margins, offset the gains reported by polyurethane polyols
and systems. Specialty products gross profit increased by $0.5 million, or 11
percent, to $5.5 million in 1999. The increase was primarily due to improved
margins.

     Average raw material costs increased approximately two percent from 1998 to
1999. Manufacturing labor costs increased due to higher fringe benefit costs and
normal annual pay raises. Total number of company employees decreased to 1,365
during 1999 from 1,372 in 1998. Depreciation expenses increased to $36.2 million
in 1999 from $34.8 million in 1998.

     Operating income was $41.8 million, a $3.6 million, or eight percent,
decrease from 1998. Operating expenses, consisting of marketing, administrative
and research expenses, increased $13.0 million, or 20 percent. Administrative
expenses climbed 50 percent due to a $10.2 million charge related to the
settlement of a lawsuit (see Environmental and Legal Matters section of this
discussion for additional information). Research expenses rose eight percent
between years mainly due to increased staffing levels to support development and
commercialization of high value added products. Marketing expenses grew two
percent over 1998.

     Pre-tax income declined 10 percent between years due mainly to the lawsuit
settlement. Interest expenses increased 12 percent due to decreased capitalized
interest and higher average levels of debt partially offset by lower average
interest rate.

     The effective tax rate was 36.5 percent in 1999 compared to 39.5 percent in
1998.  The lower effective tax rate primarily was attributable to tax losses
utilized in Europe.  An overall lower state apportionment factor and a higher
tax benefit realized

                                      15
<PAGE>

on Philippine income during 1999 also contributed to the lower effective tax
rate (see Note 6 of the Notes to the Consolidated Financial Statements for a
reconciliation of the statutory rate to the effective tax rate).

     Net income for the year was $22.1 million, or $2.08 per share diluted,
compared with $23.5 million, or $2.12 per share diluted, a year ago. Excluding
the effect of the previously discussed lawsuit settlement ($6.3 million after-
tax charge), net income would have been $28.4 million, a 21 percent increase
over 1998.

1998 Compared with 1997

Net sales for 1998 increased five percent to $610.5 million.  The increase was
primarily due to a seven percent growth in sales volume.  Net sales by segment
were as follows (prior year data has been reclassified to conform to 1999
presentation):

<TABLE>
<CAPTION>
                                                               Percent
   (Dollars in thousands)              1998          1997       Change
   ---------------------------------------------------------------------
   <S>                               <C>           <C>         <C>
   Surfactants                       $474,454      $457,109         +4
   Polymers                           116,460       105,754        +10
   Specialty Products                  19,537        19,086         +2
                                     --------      --------
      Total                          $610,451      $581,949         +5
                                     ========      ========
</TABLE>

     Surfactants net sales, accounting for 78 percent of the company's revenue,
increased $17.3 million, or four percent, from year to year. Most of the
increase was due to foreign operations, which reported a 15 percent rise in net
sales based on a 21 percent improvement in sales volume. Sales for the Colombian
subsidiary, consolidated for the first time in 1998, contributed to the foreign
results. The domestic market, which represented 79 percent of total surfactant
net sales, recorded a $4.3 million, or one percent, increase in net sales on
sales volume that stayed almost unchanged. Significantly lower export sales
volumes to Asia and Central America offset modest volume gains from U.S.
customers.

     Polymers net sales, accounting for 19 percent of the company's business,
rose 10 percent on a 25 percent increase in sales volume. Sales volume for
polyurethane polyols increased 32 percent and was the largest contributing
factor to the polymer sales growth. Polyurethane systems net sales rose six
percent on sales volume that increased 13 percent. PA net sales dropped nine
percent. A 21 percent improvement in sales volume was more than offset by
declining average selling prices. Oversupply in the marketplace, together with
lower raw material costs, led to the decline in average selling prices.

     Specialty products net sales increased two percent due to higher selling
prices.

     Gross profit rose seven percent to $111.6 million in 1998 from $104.2
million in 1997. Surfactants gross profit increased $1.7 million, or two
percent, on a three percent rise in sales volume. Domestic surfactants recorded
a $1.0 million, or two percent, rise in gross profit due to increased margins.
Lower export sales dampened the domestic result. Foreign surfactant operations
reported a $0.7 million, or five percent, increase between years. Improved sales
volumes for Mexican operations

                                      16
<PAGE>

coupled with the consolidation of the Colombian subsidiary for the first time in
1998 led to the increase. Polymers gross profit increased 22 percent to $27.8
million in 1998 from $22.8 million in 1997. The major factor for the increase
was an 80 percent improvement in global polyurethane polyols profits. Better
margins and volumes accounted for the growth. Polyurethane systems posted a one
percent increase in gross profit due to higher sales volume, partially offset by
lower margins. A shift to a less profitable sales mix was responsible for the
decline in margins. PA gross profit declined 26 percent from what was reported
in 1997. A decline in margins more than offset the increase in volume. Price
reductions due to the competitiveness brought on by oversupply in the
marketplace led to the decrease in margins. Specialty products gross profit
increased by $0.7 million, or 16 percent, reaching $5.0 million in 1998. The
improvement was primarily due to increased margins.

     Average raw material costs declined approximately three percent from 1997
to 1998. Manufacturing labor costs increases were due mainly to higher fringe
benefit costs and normal annual pay raises. Total number of employees increased
to 1,372 during 1998 from 1,292 in 1997. Most of the change occurred due to non-
manufacturing employee numbers and to employees added as a result of the
Colombian acquisition. Depreciation expense increased to $34.8 million in 1998
from $33.5 million in 1997.

     Operating income was $45.4 million, a two percent increase over 1997.
Operating expenses, consisting of marketing, administrative and research
expenses, rose 11 percent from 1997.  Administrative expenses increased 15
percent as a result of unusually high consulting fees and severance costs.  The
acquisition of Stepan Colombia also contributed to the increase.  Marketing
expenses grew 15 percent due to increased payroll costs. The acquisition of
Colombia and the start-up of operations in Brazil also added to marketing
expenses. Research costs increased three percent due mainly to the growth of
payroll cost.

     Pre-tax income rose 11 percent.  Contributing to the increase was a $2.7
million improvement in joint venture equity income.  Most of the improvement
resulted from $3.1 million of 1997 exchange loss from the devaluation of the
Philippine peso which did not recur in the same magnitude in 1998.  The 1998
exchange loss was less than $0.1 million.

     The effective tax rate was 39.5 percent in 1998 compared to 41.5 percent in
1997.  The lower effective tax rate was primarily attributable to the tax
benefit realized on Philippine income during 1998 compared to the inability to
secure a tax benefit from Philippine losses in 1997 (see Note 6 of the Notes to
the Consolidated Financial Statements for a reconciliation of the statutory rate
to the effective tax rate).

     Net income for 1998 rose to a record of $23.5 million, or $2.29 per share
($2.12 per share diluted), up 15 percent from $20.4 million, or $1.97 per share
($1.86 per share diluted), in 1997.

                                      17
<PAGE>

Fourth Quarter 1999 Compared with 1998

For the quarter ended December 31, 1999, the company reported record net income
of $8.0 million, or $0.76 per share diluted, compared to $5.6 million, or $0.51
per share diluted, in the fourth quarter of 1998.  Net sales for the quarter
grew 12 percent to $169.1 million from $150.4 million a year ago.  All segments
contributed to the sales growth.  Gross profit was up 11 percent, reaching $31.4
million in 1999.  Surfactants earnings increased $4.1 million, or 22 percent,
due to increased sales volumes for domestic and foreign operations.  Polymers
reported a $2.8 million, or 34 percent, drop in gross profit primarily due to
weaker margins and reduced sales volume.  Specialty products posted higher gross
profit due to increased sales volume of high margin products.  Consolidated
gross profit also was affected by favorable inventory adjustments (approximately
$1.0 million) related to the company's annual physical inventory, partially
offset by early retirement charges (approximately $0.8 million).  Operating
expenses rose four percent in comparison with the fourth quarter of 1998.
Higher research and development expenses accounted for most of the increase.
Fourth quarter 1999 net income was favorably affected by a $0.7 million tax
provision reduction arising from the ability to utilize tax losses from European
operations.

Liquidity and Financial Condition

For the 12 months ended December 31, 1999, net cash from operations totaled
$50.6 million, down by $8.2 million compared to 1998. Working capital amounted
to a cash use of $4.5 million for the current year compared to a $1.4 million
source for 1998. Accounts receivable increased by $15.2 million from year to
year due to increased sales as well as higher non-trade receivables. Accounts
payable and accrued liabilities were up by $10.7 million for the year-to-date
largely due to higher trade payables.

     Capital expenditures totaled $32.7 million for the year, compared to $44.1
million in 1998 due to timing of projects. Capital expenditures are expected to
increase during 2000.

     From year to year, total company debt increased by $0.6 million, to $115.1
million. As of December 31, 1999, the ratio of long-term debt to long-term debt
plus shareholders' equity was 40.9 percent compared to 42.1 percent at the end
of 1998. The company maintains contractual relationships with its domestic
banks that provide for revolving credit which may be drawn upon as needed for
general corporate purposes.  This credit facility was amended on March 12, 1999,
to increase the total amount of the commitment from $45 million to $60 million.
Other terms of the agreement remained unchanged.

     The company also meets short-term liquidity requirements through
uncommitted bank lines of credit. The company's foreign subsidiaries maintain
committed and uncommitted bank lines of credit in their respective countries to
meet working capital requirements as well as to fund capital expenditure
programs and acquisitions.

     The company anticipates that cash from operations and from committed credit
facilities will be sufficient to fund anticipated capital expenditures,
dividends and other planned financial commitments for the foreseeable future.
Any substantial acquisitions would require additional funding.

                                      18
<PAGE>

Market Risk Analysis

FOREIGN CURRENCY EXCHANGE RISK

Forward exchange contracts are used from time to time to manage currency
exposures for financial instruments denominated in currencies other than the
entity's functional currency.  The counter-parties to any such contracts are
major financial institutions, therefore the credit risk of such contracts is
considered insignificant.  Corporate policy prohibits the purchase or sale of
leveraged derivative financial instruments as well as the purchase or sale of
any derivative financial instrument for trading purposes. Any unrealized gains
or losses on cash transactions are deferred and included in the measurement of
the related foreign currency transaction. Gains or losses on unhedged foreign
currency transactions are included in income. As of December 31, 1999, the
company had no outstanding forward exchange contracts. The impact of foreign
exchange was immaterial in 1999.

     The company's 50 percent owned Philippine joint venture has U.S. dollar-
denominated debt with the potential for future translation gains or losses. A 10
percent change in this exchange rate would not have a material effect on the
company's operating results or cash flow. A substantial majority of the revenues
of the Philippine joint venture is denominated in U.S. dollars.

INTEREST RATES

The company's debt was composed of fixed-rate and variable-rate borrowings
totaling $99.9 million and $15.2 million, respectively, as of December 31, 1999.
For 2000, it is projected that interest on variable-rate borrowings will
comprise about 14 percent of the company's total interest expense. A 10 percent
increase or decrease to short-term interest rates would be immaterial to the
company's operating results or cash flow. The fair value of the company's
fixed-rate debt, including current maturities, was estimated to be $94.5 million
as of December 31, 1999, which was approximately $5.4 million below the carrying
value. Market risk was estimated as the potential increase to the fair value
that would result from a hypothetical 10 percent decrease in the company's
weighted average long-term borrowing rates at December 31, 1999, or $3.4
million. Such a rate decrease would be immaterial to future operating results or
cash flow.

COMMODITY PRICE RISK

Certain raw materials are subject to price volatility caused by weather,
petroleum prices and other unpredictable factors. In the past, the company has
had the ability to pass on raw material price increases to customers.  As a
result, the company feels that the commodity price risk is not material to the
company's consolidated financial position, results of operations or cash flow.

                                      19
<PAGE>

Environmental and Legal Matters

In the action entitled Accurso v. Stepan et al., the company reached a
                       ------------------------
settlement agreement with the plaintiffs' counsels for the 550 plaintiffs in the
mass tort action.  All terms of the settlement are confidential pursuant to a
court order.  The company recorded a $10.2 million pre-tax, or $6.3 million
after-tax, charge to earnings in 1999 as a result of the settlement.  The charge
was net of insurance recoveries and previously recorded reserves.  The
settlement payment was made in December 1999.

     The company is subject to extensive federal, state and local environmental
laws and regulations. Although the company's environmental policies and
practices are designed to ensure compliance with these laws and regulations,
future developments and increasingly stringent environmental regulation could
require the company to make additional unforeseen environmental expenditures.
The company will continue to invest in the equipment and facilities necessary to
comply with existing and future regulations. During 1999, the company's
expenditures for capital projects related to the environment were $2.7 million
and should approximate that amount for 2000. These projects are capitalized and
typically depreciated over 10 years. Recurring costs associated with the
operation and maintenance of facilities for waste treatment and disposal and
managing environmental compliance in ongoing operations at our manufacturing
locations were approximately $7.5 million for 1999 compared to $6.9 million for
1998. While difficult to project, it is not anticipated that these recurring
expenses will increase significantly in the future.

     The company has been named by the government as a potentially responsible
party at 16 waste disposal sites where cleanup costs have been or may be
incurred under the federal Comprehensive Environmental Response, Compensation
and Liability Act and similar state statutes. In addition, damages are being
claimed against the company in general liability actions for alleged personal
injury or property damage in the case of some disposal and plant sites. The
company believes that it has made adequate provisions for the costs it may incur
with respect to the sites. After partial remediation payments at certain sites,
the company has estimated a range of possible environmental and legal losses
from $4.2 million to $25.2 million at December 31, 1999, compared to $4.1
million to $26.4 million at December 31, 1998. At December 31, 1999, the
company's reserve was $11.6 million for legal and environmental matters compared
to $17.6 million at December 31, 1998. During 1999, non-capital expenditures
related to legal and environmental matters, net of insurance recoveries,
approximated $15.8 million compared to $3.6 million expended in 1998. While it
is difficult to forecast the timing of the expenditures, the company believes
that $2.0 million of the $11.6 million reserve is likely to be paid out in 2000.
The balance of the reserve would probably be paid out over many years (see also
Note 12 of the Notes to Consolidated Financial Statements).

     For certain sites, estimates cannot be made of the total costs of
compliance or the company's share of such costs; accordingly, the company is
unable to predict the effect thereof on future results of operations. In the
event of one or more adverse determinations in any annual or interim period, the
impact on results of operations for those periods could be material. However,
based upon the company's present belief as to its relative involvement at these
sites, other viable entities' responsibilities for cleanup and the extended
period over which any costs would be incurred, the company believes that these
matters will not have a material effect on the company's financial position.

                                      20
<PAGE>

Certain of these matters are discussed in Item 3, Legal Proceedings, in the 1999
Form 10-K Annual Report and in other filings of the company with the Securities
and Exchange Commission, which are available upon request from the company.

Year 2000 Readiness Disclosure

The Year 2000 issue is a result of computer systems that utilize two digits,
rather than four, to represent a given year. Computer systems used by the
company and its business partners that have date-sensitive processing may
recognize a date using "00" as the year 1900 rather than the year 2000. This
could result in a system failure or inaccurate calculation that may interrupt
normal business operations. The company established a steering team to oversee
all efforts and addressed Year 2000 compliance for three major areas:
Information Technology (IT) systems, non-IT systems and third-party
relationships. The project plan involves three phases: inventory and assessment,
remediation and testing, and implementation.

     Implementation of Year 2000 compliant upgrades of IT systems has been
completed.

     The non-IT systems are comprised of manufacturing process control,
telephone, security, laboratory and other embedded chip systems. Implementation
of Year 2000 upgrades to these systems has been completed.

     To date, the company has not experienced any significant Year 2000 problems
with its internal systems.

     The company initiated formal communications with suppliers and service
providers to determine the extent of their efforts in resolving Year 2000
issues. To date, the company has not experienced any Year 2000 issues with its
business partners.

     Costs for the Year 2000 project were $2.5 million. Of the total cost, $1.5
million was capitalized as it related to systems replacements and the remaining
was expensed as incurred. These costs are not material to the overall IT budget
and no projects were deferred due to Year 2000 efforts.

New Accounting Standard

In June 1998, the Financial Accounting Standards Board (FASB) issued Statement
of Financial Accounting Standards (SFAS) No. 133, "Accounting for Derivative
Instruments and Hedging Activities", effective for fiscal years beginning after
June 15, 1999. The standard establishes accounting and reporting requirements
for derivative instruments. In June 1999, the FASB issued SFAS No. 137, which
deferred the effective date to fiscal years beginning after June 15, 2000. The
company believes that the adoption of SFAS No. 133 in 2001 will not have a
material effect on its consolidated results of operations or financial position.

                                      21
<PAGE>

                             Report of Management

Management Report on Financial Statements

The financial statements of Stepan Company and subsidiaries were prepared by and
are the responsibility of management. The statements have been prepared in
conformity with generally accepted accounting principles appropriate in the
circumstances and include some amounts that are based on management's best
estimates and judgments. The Board of Directors, through its Audit Committee,
assumes an oversight role with respect to the preparation of the financial
statements.

     In meeting its responsibility for the reliability of the financial
statements, the company depends on its system of internal accounting control.
The system is designed to provide reasonable assurance that assets are
safeguarded and that transactions are executed as authorized and are properly
recorded. The system is augmented by written policies and procedures and an
internal audit department.

     The Audit Committee of the Board of Directors, composed solely of directors
who are not officers or employees of the company, meets regularly with
management, with the company's internal auditors and with its independent
certified public accountants to discuss its evaluation of internal accounting
controls and the quality of financial reporting. The independent auditors and
the internal auditors have free access to the Audit Committee, without
management's presence.


F. Quinn Stepan
Chairman of the Board and Chief Executive Officer



F. Quinn Stepan, Jr.
President and Chief Operating Officer



Walter J. Klein
Vice President - Finance


February 10, 2000

                                      22
<PAGE>

                   Report of Independent Public Accountants

To the Stockholders of Stepan Company:

We have audited the accompanying consolidated balance sheets of Stepan Company
(a Delaware corporation) and subsidiaries as of December 31, 1999 and 1998, and
the related consolidated statements of income, cash flows and stockholders'
equity, for each of the three years in the period ended December 31, 1999.
These consolidated financial statements are the responsibility of the company's
management.  Our responsibility is to express an opinion on these consolidated
financial statements based on our audits.

     We conducted our audits in accordance with auditing standards generally
accepted in the United States. Those standards require that we plan and perform
the audit to obtain reasonable assurance about whether the consolidated
financial statements are free of material misstatement. An audit also includes
examining, on a test basis, evidence supporting the amounts and disclosures in
the consolidated financial statements. An audit includes assessing the
accounting principles used and significant estimates made by management, as well
as evaluating the overall consolidated financial statement presentation. We
believe that our audits provide a reasonable basis for our opinion.

     In our opinion, the consolidated financial statements referred to above
present fairly, in all material respects, the financial position of Stepan
Company and subsidiaries as of December 31, 1999 and 1998, and the results of
their operations and their cash flows for each of the three years in the period
ended December 31, 1999, in conformity with accounting principles generally
accepted in the United States.



Chicago, Illinois,
February 10, 2000

                                      23
<PAGE>

                          Consolidated Balance Sheets
                          December 31, 1999 and 1998

<TABLE>
<CAPTION>
(Dollars in thousands)                                                                    1999            1998
- ---------------------------------------------------------------------------------------------------------------------
<S>                                                                                    <C>              <C>
Assets
Current Assets:
  Cash and cash equivalents                                                            $    3,969      $     983
  Receivables, less allowances of $2,389 in 1999 and $2,263 in 1998                        97,089         81,890
  Inventories (Note 3)                                                                     51,849         52,496
  Deferred income taxes (Note 6)                                                            9,361         10,572
  Other current assets                                                                      4,392          3,817
- ---------------------------------------------------------------------------------------------------------------------
  Total current assets                                                                    166,660        149,758
- ---------------------------------------------------------------------------------------------------------------------

Property, Plant and Equipment:
  Land                                                                                      5,905          6,553
  Buildings and improvements                                                               68,560         61,838
  Machinery and equipment                                                                 514,397        491,899
  Construction in progress                                                                  8,042          8,311
- ---------------------------------------------------------------------------------------------------------------------
                                                                                          596,904        568,601
  Less: Accumulated depreciation                                                          387,423        353,505
- ---------------------------------------------------------------------------------------------------------------------
  Property, plant and equipment, net                                                      209,481        215,096
- ---------------------------------------------------------------------------------------------------------------------

Other Assets                                                                               38,435         39,507
- ---------------------------------------------------------------------------------------------------------------------
  Total assets                                                                         $  414,576      $ 404,361
- ---------------------------------------------------------------------------------------------------------------------

Liabilities and Stockholders' Equity
  Current Liabilities:
  Current maturities of long-term debt (Note 4)                                        $    7,663      $   6,807
  Accounts payable                                                                         48,676         43,977
  Accrued liabilities (Note 10)                                                            41,706         37,160
- ---------------------------------------------------------------------------------------------------------------------
  Total current liabilities                                                                98,045         87,944
- ---------------------------------------------------------------------------------------------------------------------
Deferred Income Taxes (Note 6)                                                             41,975         39,920
- ---------------------------------------------------------------------------------------------------------------------
Long-term Debt, less current maturities (Note 4)                                          107,420        107,708
- ---------------------------------------------------------------------------------------------------------------------
Other Non-current Liabilities (Note 11)                                                    12,072         20,805
- ---------------------------------------------------------------------------------------------------------------------

Stockholders' Equity (Note 7):
 5 1/2 percent convertible preferred stock, cumulative, voting, without par value;
       authorized 2,000,000 shares; issued 783,003 in 1999 and 784,417
       shares in 1998                                                                      19,575         19,611
 Common stock, $1 par value; authorized 30,000,000 shares; issued
      9,684,600 shares in 1999 and 9,997,736 shares in 1998                                 9,685          9,998
 Additional paid-in capital                                                                11,909         10,962
 Accumulated other comprehensive loss                                                     (10,631)        (9,050)
 Retained earnings                                                                        134,224        127,478
- ---------------------------------------------------------------------------------------------------------------------
                                                                                          164,762        158,999
 Less:  Treasury stock, at cost                                                             9,698         11,015
- ---------------------------------------------------------------------------------------------------------------------
 Stockholders' equity                                                                     155,064        147,984
- ---------------------------------------------------------------------------------------------------------------------
 Total liabilities and stockholders' equity                                            $  414,576      $ 404,361
- ---------------------------------------------------------------------------------------------------------------------
</TABLE>

The accompanying Notes to Consolidated Financial Statements are an integral part
of these consolidated balance sheets.

                                      24
<PAGE>

                       Consolidated Statements of Income
             For the years ended December 31, 1999, 1998 and 1997

<TABLE>
<CAPTION>
(Dollars in thousands, except per share amounts)                       1999            1998            1997
- --------------------------------------------------------------------------------------------------------------------
<S>                                                                 <C>             <C>             <C>
Net Sales                                                           $  666,784      $  610,451      $  581,949
- --------------------------------------------------------------------------------------------------------------------
Cost of Sales                                                          545,839         498,856         477,778
- --------------------------------------------------------------------------------------------------------------------
Gross Profit                                                           120,945         111,595         104,171
- --------------------------------------------------------------------------------------------------------------------
Operating Expenses:
   Marketing                                                            23,799          23,365          20,394
   Administrative (Note 13)                                             32,775          21,825          18,964
   Research, development and technical services (Note 1)                22,593          20,982          20,443
- --------------------------------------------------------------------------------------------------------------------
                                                                        79,167          66,172          59,801
- --------------------------------------------------------------------------------------------------------------------

Operating Income                                                        41,778          45,423          44,370

Other Income (Expenses):
   Interest, net (Note 4)                                               (8,376)         (7,453)         (7,595)
   Income (loss) from equity joint ventures (Note 1)                     1,427             796          (1,901)
- --------------------------------------------------------------------------------------------------------------------
                                                                        (6,949)         (6,657)         (9,496)
- --------------------------------------------------------------------------------------------------------------------

Income Before Provision for Income Taxes                                34,829          38,766          34,874
Provision for Income Taxes (Note 6)                                     12,700          15,312          14,464
- --------------------------------------------------------------------------------------------------------------------
Net Income                                                          $   22,129      $   23,454      $   20,410
- --------------------------------------------------------------------------------------------------------------------

Net Income Per Common Share (Note 15):
   Basic                                                            $     2.22      $     2.29      $     1.97
- --------------------------------------------------------------------------------------------------------------------
   Diluted                                                          $     2.08      $     2.12      $     1.86
- --------------------------------------------------------------------------------------------------------------------

Average Common Shares Outstanding (Note 1)                               9,592           9,843           9,831
- --------------------------------------------------------------------------------------------------------------------
</TABLE>


The accompanying Notes to Consolidated Financial Statements are an integral part
of these statements.

                                      25
<PAGE>

                                Combined Sales

(Dollars in thousands)

<TABLE>
<CAPTION>
           Surfactants       Polymers        Specialty      Consolidated
                                              Products             Total
  <S>      <C>               <C>             <C>            <C>
  1995         394,928        115,833          17,457            528,218
  1996         414,892        103,444          18,299            536,635
  1997         457,109        105,754          19,086            581,949
  1998         474,454        116,460          19,537            610,451
  1999         524,956        121,438          20,390            666,784
</TABLE>


                        1999 Sales Dollar Distribution

(Dollars in thousands)

<TABLE>
     <S>                                  <C>               <C>
     Material                             $404,587          60.7%
     Other Expenses                       $ 89,666          13.5%
     Payroll and Fringes                  $ 98,250          14.7%
     Depreciation and Amortization        $ 39,452           5.9%
     Income Taxes                         $ 12,700           1.9%
     Net Income                           $ 22,129           3.3%
</TABLE>

                                      26
<PAGE>

                     Consolidated Statements of Cash Flows
             For the years ended December 31, 1999, 1998 and 1997


<TABLE>
<CAPTION>
(Dollars in thousands)                                                  1999          1998            1997
- ----------------------------------------------------------------------------------------------------------------
<S>                                                                <C>             <C>             <C>
Net Cash Flows from Operating Activities
  Net income                                                       $   22,129        $ 23,454        $ 20,410
  Depreciation and amortization                                        39,452          37,347          35,281
  Deferred revenue recognition                                         (5,165)         (4,327)         (3,611)
  Customer prepayments                                                      -             800           3,292
  Deferred income taxes                                                 3,745           4,244           1,114
  Environmental and legal liabilities                                  (4,999)         (3,035)           (428)
  Other non-cash items                                                    (98)           (998)          1,860
  Changes in Working Capital:
     Receivables, net                                                 (15,199)            179           3,999
     Inventories                                                          647          (2,840)          1,243
     Accounts payable and accrued liabilities                          10,676           2,731           1,069
     Other                                                               (575)          1,292          (1,364)
- ----------------------------------------------------------------------------------------------------------------
     Net Cash Provided by Operating Activities                         50,613          58,847          62,865
- ----------------------------------------------------------------------------------------------------------------

Cash Flows from Investing Activities
  Expenditures for property, plant and equipment                      (32,697)        (44,056)        (35,589)
  Investment in acquisitions                                             (450)        (21,195)         (4,999)
  Other non-current assets                                               (594)          1,587             344
- ----------------------------------------------------------------------------------------------------------------
     Net Cash Used for Investing Activities                           (33,741)        (63,664)        (40,244)
- ----------------------------------------------------------------------------------------------------------------

Cash Flows from Financing and Other
  Related Activities
  Revolving debt and notes payable to banks, net                       11,400         (10,310)          1,210
  Other debt borrowings                                                    --          30,000              --
  Other debt repayments                                               (10,832)         (6,151)         (9,660)
  Purchases of treasury stock, net                                     (8,255)         (8,402)         (8,863)
  Dividends paid                                                       (6,727)         (6,432)         (6,069)
  Stock option exercises                                                1,088           2,473           2,252
  Other non-cash items                                                   (560)           (885)           (762)
- ----------------------------------------------------------------------------------------------------------------
     Net Cash Provided by (Used for) Financing and
         Other Related Activities                                     (13,886)            293         (21,892)
- ----------------------------------------------------------------------------------------------------------------

Net Increase (Decrease) in Cash and Cash Equivalents                    2,986          (4,524)            729
Cash and Cash Equivalents at Beginning of Year                            983           5,507           4,778
- ----------------------------------------------------------------------------------------------------------------
Cash and Cash Equivalents at End of Year                           $    3,969        $    983        $  5,507
- ----------------------------------------------------------------------------------------------------------------

Supplemental Cash Flow Information
  Cash payments of income taxes, net of refunds                    $   10,564        $  9,295        $ 16,059
  Cash payments of interest                                        $    8,780        $  7,781        $  8,306
- ----------------------------------------------------------------------------------------------------------------
</TABLE>

The accompanying Notes to Consolidated Financial Statements are an integral part
of these statements.

                                      27
<PAGE>

                             Capital Expenditures
                            (Dollars in thousands)


                         1994                42,884
                         1995                39,247
                         1996                44,923
                         1997                35,589
                         1998                44,056
                         1999                32,697

                            Compound Annual Growth
                                Five Years -5%


                               Equity Per Share
                                   (Dollars)


                         1994                 10.27
                         1995                 11.25
                         1996                 12.24
                         1997                 13.01
                         1998                 14.18
                         1999                 15.20

                            Compound Annual Growth
                                Five Years +8%

                                      28
<PAGE>

                Consolidated Statements of Stockholders' Equity
             For the years ended December 31, 1999, 1998 and 1997

<TABLE>
<CAPTION>
                                                                                             Accumulated
                                           Convertible             Additional                      Other
                                             Preferred    Common      Paid-in   Treasury   Comprehensive    Retained   Comprehensive
(Dollars in thousands)                           Stock     Stock      Capital      Stock    Income (Loss)   Earnings          Income
- ------------------------------------------------------------------------------------------------------------------------------------
<S>                                        <C>            <C>      <C>          <C>        <C>              <C>        <C>
Balance, January 1, 1997                       $19,924    $10,132     $ 5,066   $ (5,200)      $ (4,820)    $ 106,513            --
Sale of 200,500 shares
 under stock option plan                            --        200       2,052         --             --            --            --
Purchase of 246,901 shares of common
 and 113,666 shares of preferred treasury
 stock, net of sales                                --         --         101     (8,863)            --            --            --
Conversion of preferred stock
 to common stock                                  (213)        10         203         --             --            --            --
Net income                                          --         --          --         --             --        20,410     $  20,410
Other comprehensive income:
 Foreign currency translation adjustments           --         --          --         --         (2,517)           --        (2,517)
                                                                                                                          ---------
Comprehensive income                                --         --          --         --             --            --     $  17,893
                                                                                                                          =========
Cash dividends paid                                 --         --          --         --             --            --            --
 Preferred stock ($1.375 per share)                 --         --          --         --             --        (1,027)           --
 Common stock (51.25c per share)                    --         --          --         --             --        (5,042)           --
Non-qualified stock option tax benefit              --         --         669         --             --            --            --
- ------------------------------------------------------------------------------------------------------------------------------------
Balance, December 31, 1997                      19,711     10,342       8,091    (14,063)        (7,337)      120,854            --
Sale of 151,200 shares
 under stock option plan                            --        151       2,322         --             --            --            --
Purchase of 288,744 shares of common
 treasury stock, net of sales                       --         --         462     (8,402)            --            --            --
Retirement of 500,000 shares of common treasury
 stock                                              --       (500)       (552)    11,450             --       (10,398)           --
Conversion of preferred stock
 to common stock                                  (100)         5          96         --             --            --            --
Net income                                          --         --          --         --             --        23,454     $  23,454
Other comprehensive income:
 Foreign currency translation adjustments           --         --          --         --         (1,713)           --        (1,713)
                                                                                                                          ---------
Comprehensive income                                --         --          --         --             --            --     $  21,741
                                                                                                                          =========
Cash dividends paid                                 --         --          --         --             --            --            --
 Preferred stock ($1.375 per share)                 --         --          --         --             --          (896)           --
 Common stock (56.25c per share)                    --         --          --         --             --        (5,536)           --
Non-qualified stock option tax benefit              --         --         543         --             --            --            --
- -----------------------------------------------------------------------------------------------------------------------------------
Balance, December 31, 1998                      19,611      9,998      10,962    (11,015)        (9,050)      127,478            --
Sale of 85,250 shares
 under stock option plan                            --         85       1,003         --             --            --            --
Purchase of 317,048 shares of common
 and 38,646 shares of preferred treasury
 stock, net of sales                                --         --           4     (8,255)            --            --            --
Retirement of 400,000 shares of common
 treasury stock                                     --       (400)       (516)     9,572             --        (8,656)           --
Conversion of preferred stock
 to common stock                                   (36)         2          34         --             --            --            --
Net income                                          --         --          --         --             --        22,129     $  22,129
Other comprehensive income:
 Foreign currency translation adjustments           --         --          --         --         (1,581)           --        (1,581)
                                                                                                                          ---------
Comprehensive income                                --         --          --         --             --            --     $  20,548
                                                                                                                          =========
Cash dividends paid                                 --         --          --         --             --            --            --
 Preferred stock ($1.375 per share)                 --         --          --         --             --          (858)           --
 Common stock (61.25c per share)                    --         --          --         --             --        (5,869)           --
Non-qualified stock option tax benefit              --         --         422         --             --            --            --
- ------------------------------------------------------------------------------------------------------------------------------------
Balance, December 31, 1999                     $19,575    $ 9,685     $11,909   $ (9,698)      $(10,631)    $ 134,224            --
- ------------------------------------------------------------------------------------------------------------------------------------
</TABLE>

     The accompanying Notes to Consolidated Financial Statements are an integral
part of these statements.

                                      29
<PAGE>

                  Notes to Consolidated Financial Statements
             For the years ended December 31, 1999, 1998 and 1997


1.  Summary of Significant Accounting Policies

Nature of Operations

The company's operations consist predominantly of the production and sale of
specialty and intermediate chemicals which are sold to other manufacturers for
use in a variety of end products. Principal markets for all products are
manufacturers of cleaning and washing compounds (including detergents, shampoos,
toothpastes and household cleaners), paints, cosmetics, food and beverages,
agricultural products, plastics, furniture, automotive equipment, insulation and
refrigeration.

     The company grants credit to its customers who are widely distributed
across the Americas, Europe, Asia and the Pacific. There is no material
concentration of credit risk.

Principles of Consolidation

The consolidated financial statements include the accounts of Stepan Company and
its wholly owned foreign subsidiaries. All significant intercompany balances and
transactions have been eliminated in consolidation. The investment in the 50
percent owned joint venture in the Philippines is accounted for on the equity
method and is included in the "Other Assets" caption on the Consolidated Balance
Sheet. The company's share of the net earnings of the investment is included in
consolidated net income.

Cash and Cash Equivalents

The company considers all highly liquid investments with original maturities of
six months or less from the date of purchase to be cash equivalents.

Inventories

Inventories are valued at cost, which is not in excess of market value, and
include material, labor and plant overhead costs. The last-in, first-out (LIFO)
method is used to determine the cost of most company inventories. The first-in,
first-out (FIFO) method is used for all other inventories. Inventories priced at
LIFO as of December 31, 1999 and 1998, amounted to 86 percent of total
inventories.

Property, Plant and Equipment

Depreciation of physical properties is provided on a straight-line basis over
the estimated useful lives of various assets. Lives used for calculating
depreciation are 30 years for buildings, 15 years for building improvements and
from three to 15 years for machinery and equipment. Major renewals and
betterments are capitalized in the property accounts, while maintenance and
repairs ($17,815,000, $18,350,000 and

                                      30
<PAGE>

$18,775,000 in 1999, 1998 and 1997, respectively), which do not renew or extend
the life of the respective assets, are charged to operations currently. The cost
of property retired or sold and the related accumulated depreciation are removed
from the accounts and any resulting gain or loss is reflected in income.

     Interest charges on borrowings applicable to major construction projects
are capitalized and subsequently amortized over the lives of the related assets.

Revenue Recognition

Revenue is recognized upon shipment of goods to customers.

Environmental Expenditures

Environmental expenditures that relate to current operations are expensed or
capitalized as appropriate. Expenditures that relate to an existing condition
caused by past operations, and which do not contribute to current or future
revenue generation, are expensed. Liabilities are recorded when environmental
assessments and/or remedial efforts are probable and the cost or range of
possible costs can be reasonably estimated. When no amount within the range is a
better estimate than any other amount, at least the minimum is accrued. Some of
the factors on which the company bases its estimates include information
provided by feasibility studies, potentially responsible party negotiations and
the development of remedial action plans. Expenditures that mitigate or prevent
environmental contamination and that benefit future operations are capitalized.
Capitalized expenditures are depreciated generally utilizing a 10 year life. See
Note 12 for contingency information.

Intangible Assets

Included in other assets are intangible assets consisting of patents, agreements
not to compete, trademarks, customer lists and goodwill, all of which were
acquired as part of business acquisitions. These assets are presented net of
amortization provided on a straight-line basis over their estimated useful lives
generally ranging from five to 15 years.

Research and Development Costs

The company's research and development costs are expensed as incurred. These
expenses are aimed at discovery and commercialization of new knowledge with the
intent that such effort will be useful in developing a new product or in
bringing about a significant improvement to an existing product or process.
Total expenses were $13,113,000, $12,219,000 and $12,404,000 in 1999, 1998 and
1997, respectively. The balance of expenses reflected on the Consolidated
Statements of Income relates to technical services which include routine product
testing, quality control and sales support service.

                                      31
<PAGE>

Income Taxes

The provision for income taxes includes federal, foreign, state and local income
taxes currently payable and those deferred because of temporary differences
between the financial statement and tax bases of assets and liabilities.
Deferred tax assets or liabilities are computed based on the difference between
the financial statement and income tax bases of assets and liabilities using the
enacted marginal tax rate.  Deferred income tax expenses or credits are based on
the changes in the asset or liability from period to period.

Translation of Foreign Currencies

Assets and liabilities of consolidated foreign subsidiaries are translated into
U.S. dollars at exchange rates in effect at year end. The resulting translation
adjustments are included in stockholders' equity. Revenues and expenses are
translated at average exchange rates prevailing during the year. Gains or losses
on foreign currency transactions and the related tax effects are reflected in
net income.

Derivative Financial Instruments

The company's utilization of derivative financial instruments consists of the
use of forward exchange contracts to hedge firm foreign currency commitments.
The unrealized gains and losses are deferred and included in the measurement of
the related foreign currency transaction. Gains and losses on unhedged foreign
currency transactions are included in income.

Long-Lived Assets

The company's accounting policies require that operating assets and associated
goodwill be written down to fair value whenever an impairment review indicates
that the carrying value cannot be recovered on an undiscounted cash flow basis.
The company has determined that no impairment loss has needed to be recognized
for applicable assets of continuing operations.

Stock-Based Compensation

Statement of Financial Accounting Standards No. 123, "Accounting for Stock-Based
Compensation," encourages, but does not require companies to record compensation
cost for stock-based employee compensation plans at fair value.  The company has
chosen to continue to account for stock-based compensation using the intrinsic
value method prescribed in Accounting Principles Board Opinion No. 25,
"Accounting for Stock Issued to Employees," and related interpretations.
Accordingly, compensation cost for stock options is measured as the excess, if
any, of the quoted market price of the company's stock at the date of the grant
over the amount an employee must pay to acquire the stock.  See Note 8 for stock
option plan information.

                                      32
<PAGE>

Per Share Data

Basic earnings per share amounts are computed based on the weighted-average
number of common shares outstanding. Net income used in computing basic earnings
per share has been reduced by dividends paid to preferred stockholders. Diluted
earnings per share amounts are based on the increased number of common shares
that would be outstanding assuming the exercise of certain outstanding stock
options and the conversion of the convertible preferred stock, when such
conversion would have the effect of reducing earnings per share. See Note 15 for
the computation of earnings per share.

Comprehensive Income

Comprehensive income includes net income and all other nonowner changes in
equity that are not reported in net income. For the twelve months ended December
31, 1999, 1998 and 1997, the company's comprehensive income included net income
and foreign currency translation gains and losses. Comprehensive income is
disclosed in the Consolidated Statements of Stockholders' Equity.

Segment Reporting

The company reports financial and descriptive information about its reportable
operating segments. Operating segments are components of the company that have
separate financial information that is regularly evaluated by the chief
operating decision maker to assess segment performance and allocate resources.
The company discloses segment revenue, operating income, assets, capital
expenditures and depreciation and amortization expenses. Enterprise-wide
financial information about the revenues derived from the company's products,
the geographic locations in which the company earns revenues and holds assets
and major customers (i.e. any customer accounting for 10 percent or more of the
company's revenue) is also disclosed. See Note 14 for segment reporting
information.

Software Development Costs

In 1999, the company adopted Statement of Position (SOP) 98-1, "Accounting for
the Cost of Computer Software Developed or Obtained for Internal Use". SOP 98-1
provides guidance on accounting for costs related to obtaining or developing
internal-use software. The adoption does not have a material impact on the
company's operating results or financial position.

Reclassifications

Certain amounts in the 1998 and 1997 financial statements have been reclassified
to conform to the 1999 presentation.

                                      33
<PAGE>

Use of Estimates

The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial statements and
the reported amounts of revenues and expenses during the reporting period.
Actual results could differ from those estimates.

2.   Acquisitions

On May 8, 1998, the company purchased an additional 34.5 percent of the
outstanding stock of Stepan Colombia raising its stake in the Colombia company
to 84.5 percent. On August 19, 1998, the remaining shares (15.5 percent) were
acquired. As a result, Stepan Colombia became a wholly-owned subsidiary. The
transaction was accounted for as a step acquisition purchase, and Stepan
Colombia's financial results have been reported on a consolidated basis from the
date that controlling interest was acquired. Prior to the May 1998 purchase
date, the investment was accounted for under the equity method. The reported
consolidated results of operations for 1997 and 1998 would not have been
materially affected had this transaction occurred at the beginning of 1997.

     Effective June 30, 1998, the company acquired selected specialty surfactant
product lines from E.I. DuPont De Nemours Company. The acquired business
consists of phosphate esters, specialty ethoxylates and other specialty
quaternaries and polymers sold to the plastic and fiber industries. The product
lines supplement the company's existing surfactants and polymers businesses and
will be produced in current company manufacturing plants. The transaction was
recorded as a purchase of intangible assets, including patents, trademarks,
know-how and goodwill.

     On November 11, 1998, the company's wholly owned subsidiary, Stepan Canada,
Inc., acquired the Canadian anionic and cationic surfactant business from Boehme
Filatex Canada, Inc. The acquired product lines are sold primarily into the
personal care and the institutional cleaning product markets. No manufacturing
facilities were included in this acquisition. The transaction was recorded as a
purchase of intangible assets, including goodwill, non-compete agreement, know-
how, patents and trademarks.

     In April 1997, the company acquired the West Coast anionic surfactant
business from Lonza, Inc. The acquisition consisted of intangible assets,
including customer lists, goodwill, know-how and a non-compete covenant. No
manufacturing facilities were included in the agreement. The acquisition enables
the company to significantly strengthen its market share in the personal care
market on the West Coast.

                                      34
<PAGE>

3.   Inventories

The composition of inventories was as follows:

<TABLE>
<CAPTION>
                                                December 31
                                     ----------------------------
   (Dollars in thousands)                1999           1998
   --------------------------------------------------------------
   <S>                               <C>               <C>
   Finished products                    $32,729        $33,444
   Raw materials                         19,120         19,052
   --------------------------------------------------------------
         Total inventories              $51,849        $52,496
   ==============================================================
</TABLE>

If the first-in, first-out (FIFO) inventory valuation method had been used,
inventories would have been approximately $10,600,000 and $10,000,000 higher
than reported at December 31, 1999 and 1998, respectively.

4.    Debt

Debt was composed of the following:

<TABLE>
<CAPTION>
                                                                  December 31
                                                      ----------------------------------
(Dollars in thousands)               Maturity Dates          1999             1998
- ----------------------------------------------------------------------------------------
<S>                                  <C>              <C>                  <C>
Unsecured promissory notes
         6.59%                           2003-2013          $ 30,000         $ 30,000
         7.22%                           2000-2007            24,000           30,000
         7.77%                           2000-2010            30,000           30,000
         7.69%                           2001-2005            10,000           10,000
         9.70%                           2000-2003             4,000            6,000
         9.52%                             1999                   --            1,429
         9.70%                             1999                   --              667
Unsecured bank debt                        2003               14,500            3,100
Debt of foreign subsidiaries
   payable in foreign currency           2000-2006             2,583            3,319
- ----------------------------------------------------------------------------------------
         Total debt                                          115,083          114,515
         Less current maturities                               7,663            6,807
- ----------------------------------------------------------------------------------------
                Long-term debt                              $107,420         $107,708
========================================================================================
</TABLE>

Unsecured bank debt at December 31, 1999, consisted of borrowings under a
committed $60,000,000 revolving credit agreement with interest at varying rates
averaging 5.89 percent during the year. The agreement requires a commitment fee
to be paid on the unused portion of the commitment which averaged 0.15 percent
during the year. Periodically, the company also had other borrowings under notes
payable to banks under which there were no outstanding balances at December 31,
1999 and 1998.

     The various loan agreements contain provisions which, among others, require
maintenance of certain financial ratios and place limitations on additional
debt, investments and payment of dividends. Unrestricted retained earnings were
$48,329,000 and $44,346,000 at December 31, 1999 and 1998, respectively. The
company is in compliance with all loan agreements.

                                      35
<PAGE>

     Debt at December 31, 1999, matures as follows: $7,663,000 in 2000;
$9,049,000 in 2001; $9,020,000 in 2002; $26,245,000 in 2003; $10,743,000 in 2004
and $52,363,000 after 2004.

     Net interest expense for the years ended December 31 was composed of the
following:

<TABLE>
<CAPTION>
(Dollars in thousands)                1999             1998          1997
- ----------------------------------------------------------------------------
<S>                                 <C>              <C>           <C>
Interest expense                    $ 8,661          $ 8,235       $ 8,205
Interest income                        (211)            (364)         (173)
- ----------------------------------------------------------------------------
                                      8,450            7,871         8,032
Capitalized interest                    (74)            (418)         (437)
- ----------------------------------------------------------------------------
     Interest, net                  $ 8,376          $ 7,453       $ 7,595
============================================================================
</TABLE>

5.   Leased Properties

The company leases certain property and equipment (primarily transportation
equipment, buildings and computer equipment) under operating leases. Total
rental expense was $3,661,000, $3,918,000 and $3,884,000 in 1999, 1998 and 1997,
respectively.

     Minimum future rental payments under operating leases with terms in excess
of one year as of December 31, 1999, are:

<TABLE>
<CAPTION>
(Dollars in thousands)                         Year               Amount
- -------------------------------------------------------------------------
<S>                              <C>                             <C>
                                               2000              $ 3,183
                                               2001                2,067
                                               2002                1,580
                                               2003                1,284
                                               2004                1,196
                                 Subsequent to 2004                5,868
- -------------------------------------------------------------------------
               Total minimum future rental payments              $15,178
=========================================================================
</TABLE>

                                      36
<PAGE>

6.   Income Taxes

The provision for taxes on income and the related income before taxes are as
follows:

<TABLE>
<CAPTION>
Taxes on Income
(Dollars in thousands)              1999          1998           1997
- -----------------------------------------------------------------------
<S>                               <C>            <C>           <C>
Federal
    Current                       $ 6,618        $ 8,544       $ 11,321
    Deferred                        2,280          3,285           (321)
State
    Current                         1,301          1,704          1,953
    Deferred                          506            718            502
Foreign
    Current                         1,983          1,047          1,451
    Deferred                           12             14           (442)
- -----------------------------------------------------------------------
            Total                 $12,700        $15,312       $ 14,464
=======================================================================
Income before Taxes
(Dollars in thousands)                            1998           1997
- -----------------------------------------------------------------------
Domestic                          $29,163        $35,766       $ 31,758
Foreign                             5,666          3,000          3,116
- -----------------------------------------------------------------------
         Total                    $34,829        $38,766       $ 34,874
=======================================================================
</TABLE>

     No federal income taxes have been provided on $30,145,000 of undistributed
earnings of the company's foreign subsidiaries. In general, the company
reinvests earnings of foreign subsidiaries in their operations indefinitely.
However, the company will repatriate earnings from a subsidiary where excess
cash has accumulated and it is advantageous for tax or foreign exchange reasons.
Because of the probable availability of foreign tax credits, it is not
practicable to estimate the amount, if any, of the deferred tax liability on
earnings reinvested indefinitely.

     The variations between the effective and statutory federal income tax rates
are summarized as follows:

<TABLE>
<CAPTION>
                                                                1999                       1998                     1997
- -------------------------------------------------------------------------------------------------------------------------
(Dollars in thousands)                              Amount         %          Amount          %         Amount        %
- -------------------------------------------------------------------------------------------------------------------------
<S>                                                 <C>         <C>         <C>            <C>         <C>           <C>
Income tax provision at statutory tax rate           $12,190    35.0        $13,568        35.0        $12,206       35.0
State taxes on income
   less applicable federal tax benefit                 1,175     3.4          1,574         4.1          1,215        3.5
Effect of equity in foreign joint ventures              (499)   -1.4           (278)       -0.7            665        1.9
Other items                                             (166)   -0.5            448         1.1            378        1.1
- -------------------------------------------------------------------------------------------------------------------------
     Total income tax provision                      $12,700    36.5        $15,312        39.5        $14,464       41.5
=========================================================================================================================
</TABLE>

                                      37
<PAGE>

     The net deferred tax liability at December 31 is comprised of the
following:

<TABLE>
<CAPTION>
(Dollars in thousands)                                   1999             1998
- -----------------------------------------------------------------------------------
<S>                                                     <C>              <C>
Current deferred income taxes
   Gross assets                                         $ 10,148         $ 11,203
   Gross liabilities                                        (787)            (631)
- -----------------------------------------------------------------------------------
      Total current deferred tax assets                    9,361           10,572
Non-current deferred income taxes
   Gross assets                                            7,001            7,073
   Gross liabilities                                     (48,976)         (46,993)
- -----------------------------------------------------------------------------------
      Total non-current deferred tax liabilities         (41,975)         (39,920)
- -----------------------------------------------------------------------------------
   Net deferred tax liability                           $(32,614)        $(29,348)
===================================================================================
</TABLE>

At December 31, the tax effect of significant temporary differences representing
deferred tax assets and liabilities is as follows:

<TABLE>
<CAPTION>
(Dollars in thousands)                                      1999            1998
- --------------------------------------------------------------------------------------
<S>                                                       <C>             <C>
Tax over book depreciation                                $(45,104)       $(43,884)
Safe Harbor leases                                          (2,576)         (2,795)
SFAS No. 87 pension accounting                              (2,736)         (3,043)
State income tax accrual                                     2,408           2,062
Deferred revenue                                             2,340           4,505
Book reserves deductible in other periods                   12,456          13,966
Other, net                                                     598            (159)
- --------------------------------------------------------------------------------------
     Net deferred tax liability                           $(32,614)       $(29,348)
======================================================================================
</TABLE>

7.   Stockholders' Equity

The company's preferred stock is convertible at the option of the holder at any
time (unless previously redeemed) into shares of common stock at a conversion of
1.14175 shares of common stock for each share of preferred stock. Dividends on
preferred stock accrue at a rate of $1.375 per share per annum which are
cumulative from the date of original issue. The company may not declare and pay
any dividend or make any distribution of assets (other than dividends or other
distribution payable in shares of common stock) or redeem, purchase or otherwise
acquire, shares of common stock, unless all accumulated and unpaid preferred
dividends have been paid or are contemporaneously declared and paid. The
preferred stock is subject to optional redemption by the company, in whole or in
part, at any time on or after September 1, 1997, at a redemption price of $25.69
per share reduced annually by $0.14 per share to a minimum of $25 per share on
or after September 1, 2002, plus accrued and unpaid dividends thereon to the
date fixed for redemption. Preferred stock is entitled to 1.14175 votes per
share on all matters submitted to stockholders for action, and votes together
with the common stock as a single class, except as otherwise provided by law or
the Certificate of Incorporation of the company. There is no mandatory
redemption or sinking fund obligation with respect to the preferred stock.

                                      38
<PAGE>

     On May 11, 1999, shareholders approved an amendment to the company's
Certificate of Incorporation which increased the number of authorized shares of
common stock, par value $1 per share, from 15,000,000 shares to 30,000,000
shares.

     On December 17, 1999, 400,000 shares of common stock held in treasury were
retired in accordance with the Board of Directors' authorization. At December
31, 1999, treasury stock consists of 172,520 shares of preferred stock and
196,864 shares of common stock. On December 8, 1998, 500,000 shares of common
stock held in treasury were retired in accordance with the Board of Directors'
authorization. At December 31, 1998, treasury stock consisted of 133,874 shares
of preferred stock and 305,048 shares of common stock.

8.   Stock Option Plans

The company has two fixed stock option plans: the 1982 Plan and the 1992 Plan.
The 1992 Plan extends participation to directors who are not employees of the
company. No further grants may be made under the 1982 Plan. The 1992 Plan
authorizes the award of up to 1,600,000 shares of the company's common stock for
stock options ("options") and stock appreciation rights ("SAR"). SARs entitle
the employee to receive an amount equal to the difference between the fair
market value of a share of stock at the time the SAR is exercised and the
exercise price specified at the time the SAR is granted. Options are granted at
the market price on the date of grant. An option may not be exercised within two
years from the date of grant and no option will be exercisable after 10 years
from the date granted.

     The company accounts for these plans under APB Opinion No. 25, under which
no compensation cost has been recognized.  Had compensation cost for the 1992
Plan been determined based on the fair value at the grant date for awards in
1999, 1998 and 1997 consistent with the provisions of SFAS No. 123, the
company's net income and earnings per share would have been reduced to the
following pro forma amounts:

<TABLE>
<CAPTION>
(In thousands, except per share data)              1999          1998          1997
- ---------------------------------------------------------------------------------------
<S>                                               <C>           <C>           <C>
Net Earnings - as reported                        $22,129       $23,454       $20,410
Net Earnings - pro forma                           21,272        22,575        19,716
Basic Earnings per share - as reported               2.22          2.29          1.97
Basic Earnings per share - pro forma                 2.13          2.20          1.90
Diluted Earnings per share - as reported             2.08          2.12          1.86
Diluted Earnings per share - pro forma               2.01          2.05          1.80
- ---------------------------------------------------------------------------------------
</TABLE>

     The fair value of each option grant is estimated on the date of grant using
the Black-Scholes option-pricing model with the following weighted-average
assumptions used for grants in 1999, 1998 and 1997: expected dividend yield of
2.5 percent in 1999 and 1998 and 2.7 percent in 1997.  Expected volatility of
26.7 percent in 1999, 27.0 percent in 1998 and 28.0 percent in 1997; expected
lives of 7.5 years; and risk-free interest rate of 5.21 percent in 1999, 5.75
percent in 1998 and 6.24 percent in 1997.

                                      39

<PAGE>

     A summary of the status of the company's stock option plans at December 31,
1999, 1998 and 1997, and changes during the years then ended is presented as
follows:

<TABLE>
<CAPTION>
                                                                      Weighted
                                                                      -Average
                                                      1999            Exercise            1998              1997
                                                     Shares              Price          Shares            Shares
- -----------------------------------------------------------------------------------------------------------------
<S>                                                 <C>               <C>           <C>               <C>
Options outstanding, beginning of year               1,247,591        $ 18.76        1,168,252         1,266,252
Options exercised                                      (85,250)         12.76         (151,200)         (200,500)
Options canceled                                        (4,036)         30.97           (3,229)           (4,000)
Options granted                                         64,058          23.42          233,768           106,500
- -----------------------------------------------------------------------------------------------------------------
Options outstanding, end of year                     1,222,363          19.38        1,247,591         1,168,252
- -----------------------------------------------------------------------------------------------------------------
Option price range at end of year                   $    9.438-                     $    9.438-       $    9.438-
                                                        30.969                          30.969            19.750
Option price range for exercised shares                  9.438-                          9.438-            9.438-
                                                        19.750                          19.750            18.219
- -----------------------------------------------------------------------------------------------------------------
Options available for grant at end of year             255,561                         315,583           546,122
- -----------------------------------------------------------------------------------------------------------------
Weighted-average fair value of options,
 granted during the year                            $     6.98                      $     9.64        $     6.18
- -----------------------------------------------------------------------------------------------------------------
</TABLE>

     A summary of stock options outstanding at December 31, 1999, is as follows:

<TABLE>
<CAPTION>
                                                      Options Outstanding                 Options Exercisable
                                             -----------------------------------------------------------------------
                                                    Weighted-
                                                      Average            Weighted                         Weighted
                                    Number          Remaining            -Average            Number       -Average
Range of                       Outstanding        Contractual            Exercise       Exercisable       Exercise
Exercise Price                 at 12/31/99               Life               Price       at 12/31/99          Price
- --------------------------------------------------------------------------------------------------------------------
<S>                            <C>                <C>                   <C>             <C>               <C>
   $9.438                         54,800               1.33             $   9.44           54,800         $    9.44
$12.563 - $14.000                400,300               5.09                13.86          400,300             13.86
$18.219 - $30.969                767,263               7.51                22.97          476,702             19.16
                               ---------                                                ---------
                               1,222,363               6.44              $ 19.38          931,802         $   16.31
                               =========                                                =========
</TABLE>

9.   Pension Plans

The company has non-contributory defined benefit plans covering substantially
all employees. The benefits under these plans are based primarily on years of
service and compensation levels. The company funds the annual provision
deductible for income tax purposes. The plans' assets consist principally of
marketable equity securities and government and corporate debt securities. The
plans' assets at December 31, 1999, and 1998, included $9,818,000 and
$11,183,000, respectively, of the company's common stock.

                                      40
<PAGE>

Net 1999, 1998 and 1997 periodic pension cost for the plans consists of the
following:

<TABLE>
<CAPTION>
  (Dollars in thousands)                                1999            1998            1997
  ----------------------------------------------------------------------------------------------
  <S>                                                 <C>             <C>             <C>
  Service cost                                        $  2,344        $  1,969        $  1,754
  Interest cost on projected benefit obligation          3,629           3,262           3,029
  Expected return on plan assets                        (5,156)         (4,658)         (4,158)
  Amortization of unrecognized net transition
  assets                                                  (567)           (567)           (567)
  Amortization of unrecognized prior service cost          287             269             268
  Amortization of unrecognized net loss/(gain)              14              (5)             (4)
  ----------------------------------------------------------------------------------------------
       Net pension expense                            $    551        $    270        $    322
  ==============================================================================================
</TABLE>

Changes in benefit obligations for the years ending December 31, 1999 and 1998
were as follows:

<TABLE>
<CAPTION>
     (Dollars in thousands)                    1999            1998
     ------------------------------------------------------------------
     <S>                                      <C>             <C>
     Benefit obligation at beginning of       $ 53,169        $ 44,391
      year
     Service cost                                2,344           1,969
     Interest cost                               3,629           3,262
     Plan amendments                               515              23
     Actuarial (gain)/loss                      (7,217)          5,064
     Benefits paid                              (1,713)         (1,540)
     ------------------------------------------------------------------
          Benefit obligation at end of year   $ 50,727        $ 53,169
     ==================================================================
</TABLE>

Changes in the fair value of plan assets during fiscal years 1999 and 1998 were
as follows:

<TABLE>
<CAPTION>
  (Dollars in thousands)                             1999             1998
  -----------------------------------------------------------------------------
  <S>                                               <C>              <C>
  Fair value of plan assets at beginning of         $ 67,183         $ 64,786
   year
  Actual return on plan assets                        10,778            3,350
  Employer contributions                                  --              587
  Benefits paid                                       (1,713)          (1,540)
  -----------------------------------------------------------------------------
       Fair value of plan assets at end of the year $ 76,248         $ 67,183
  =============================================================================
</TABLE>

The reconciliation of the funded status of the plans to the amount reported in
the company's consolidated balance sheet is as follows:

<TABLE>
<CAPTION>
  (Dollars in thousands)                               1999             1998
  -----------------------------------------------------------------------------
  <S>                                                 <C>              <C>
  Plan assets in excess of projected  benefit         $ 25,522         $ 14,014
   obligations
  Unrecognized net transition assets                      (567)          (1,134)
  Unrecognized prior service cost                        1,767            1,748
  Unrecognized net gain                                (20,240)          (7,386)
  -----------------------------------------------------------------------------
    Prepaid benefit cost                              $  6,482         $  7,242
  =============================================================================
</TABLE>

                                      41
<PAGE>

The prepaid pension asset is included in the "Other Assets" caption on the
Consolidated Balance Sheets. The weighted-average assumptions as of December 31,
1999, 1998 and 1997, were as follows:

<TABLE>
<CAPTION>
                                         1999            1998          1997
- -----------------------------------------------------------------------------------
<S>                                   <C>             <C>            <C>
Discount rate                            7.75%           6.75%          7.25%
Expected return on plan assets           8.50%           8.50%          8.50%
Rate of compensation increase         4.25%-6.25%     4.25%-6.25%    4.50%-6.50%
- -----------------------------------------------------------------------------------
</TABLE>

The plans' net transitional assets are being amortized over a period of 15
years. The prior service costs are being amortized over an average of 12 years.

10.  Accrued Liabilities

Accrued liabilities consisted of:

<TABLE>
<CAPTION>
                                                          December 31
                                           -----------------------------------
(Dollars in thousands)                              1999               1998
- ------------------------------------------------------------------------------
<S>                                        <C>                    <C>
Accrued payroll and benefits                      $ 17,421        $   14,236
Accrued customer discounts                           8,007             6,760
Deferred revenue -- current                          3,020             4,451
Other accrued liabilities                           13,258            11,713
- ------------------------------------------------------------------------------
     Total accrued liabilities                    $ 41,706        $   37,160
- ------------------------------------------------------------------------------
</TABLE>

11.  Other Non-current Liabilities

Other non-current liabilities were comprised of the following:


<TABLE>
<CAPTION>
                                                                  December 31
                                                   ---------------------------------------
(Dollars in thousands)                                      1999               1998
- ------------------------------------------------------------------------------------------
<S>                                                <C>                       <C>
Deferred revenue                                          $ 2,508            $ 6,242
Environmental and legal matters (Note 12)                   9,564             14,563
- ------------------------------------------------------------------------------------------
     Total other non-current liabilities                  $12,072            $20,805
- ------------------------------------------------------------------------------------------
</TABLE>

During and prior to 1998, the company received prepayments on certain multi-year
commitments for future shipments of products. As the commitments are fulfilled,
a proportionate share of the deferred revenue is recognized into income. In
1999, approximately $1.4 million of previously deferred revenue was accelerated
and recorded in net sales when a customer released the company from further
performance under a prepaid contract that originally extended into the year
2000. Related deferred revenue at December 31, 1999 and 1998, is $5,528,300 and
$10,693,000, respectively, of which the amount recognizable within one year is
included in the "Accrued Liabilities" caption of the Consolidated Balance
Sheets.

12.  Contingencies

There are a variety of legal proceedings pending or threatened against the
company. Some of these proceedings may result in fines, penalties, judgments or
costs being assessed against the company at some future time. The company's
operations are

                                      42
<PAGE>

subject to extensive local, state and federal regulations, including the federal
Comprehensive Environmental Response, Compensation and Liability Act of 1980
("Superfund") and the Superfund amendments of 1986. The company, and others,
have been named as potentially responsible parties at affected geographic sites.
As discussed in Management's Discussion and Analysis of Financial Condition and
Results of Operations, the company believes that it has made adequate provisions
for the costs it may incur with respect to these sites.

     After partial remediation payments at certain sites, the company has
estimated a range of possible environmental and legal losses from $4.2 million
to $25.2 million at December 31, 1999, compared to $4.1 million to $26.4 million
at December 31, 1998. At December 31, 1999, the company's reserve was $11.6
million for legal and environmental matters compared to $17.6 million at
December 31, 1998. The company made payments of $15.8 million, net of insurance
recoveries, in 1999 and $3.6 million in 1998 related to legal costs, settlements
and costs related to remedial design studies at various sites.

     For certain sites, estimates cannot be made of the total costs of
compliance, or the company's share of such costs; accordingly, the company is
unable to predict the effect thereof on future results of operations. In the
event of one or more adverse determinations in any annual or interim period, the
impact on results of operations for those periods could be material. However,
based upon the company's present belief as to its relative involvement at these
sites, other viable entities' responsibilities for cleanup, and the extended
period over which any costs would be incurred, the company believes that these
matters will not have a material effect on the company's financial position.
Certain of these matters are discussed in Item 3, Legal Proceedings, in the 1999
Form 10-K Annual Report and in other filings of the company with the Securities
and Exchange Commission, which filings are available upon request from the
company.

13.  Legal Settlement

On December 1, 1999, the company settled a lawsuit in New Jersey, for alleged
personal injuries related to environmental claims. All terms of the settlement
are confidential pursuant to a court order. As a result of this settlement, the
company incurred a $6.3 million after-tax charge ($0.59 per share diluted). The
charge was net of insurance recoveries and previously recorded reserves and was
included in administrative expenses.

14.  Segment Reporting

Stepan Company has three reportable segments: surfactants, polymers and
specialty products. Each segment provides distinct products and requires
separate management due to unique markets, technologies and production
processes. Surfactants are used in a variety of consumer and industrial cleaning
compounds as well as in agricultural products, lubricating ingredients and other
specialized applications. Polymers derives its revenues from the sale of
phthalic anhydride, polyurethane polyols and polyurethane systems used in
plastics, building materials and refrigeration systems. Specialty products sells
chemicals used in food, flavoring and pharmaceutical applications.

                                      43
<PAGE>

     The company evaluates the performance of its segments and allocates
resources based on operating income before interest income/expense, other
income/expense items and income tax provisions. The accounting policies of the
reportable segments are the same as those described in the summary of
significant accounting policies. There is no intersegment revenue and all
intercompany transactions are eliminated from segments' revenue.

Segment data for the three years ended December 31, 1999, 1998 and 1997, is as
follows (prior year data has been reclassified to conform to 1999 presentation):

<TABLE>
<CAPTION>
                                                                        Specialty   Segment
     (Dollars in thousands)                 Surfactants     Polymers    Products    Totals
     -----------------------------------------------------------------------------------------
     <S>                                  <C>              <C>          <C>        <C>
             1999
             ----
     Net sales                                $524,956      $121,438    $20,390   $666,784
     Operating income                           51,123        21,453      4,454     77,030
     Assets                                    315,580        52,434     18,760    386,774
     Capital expenditures                       24,423         4,846        807     30,076
     Depreciation and amortization expenses     31,091         5,856      1,128     38,075
     -----------------------------------------------------------------------------------------

             1998
             ----
     Net sales                                $474,454      $116,460    $19,537   $610,451
     Operating income                           41,997        21,811      3,511     67,319
     Assets                                    315,549        48,795     17,478    381,822
     Capital expenditures                       37,091         3,632      1,652     42,375
     Depreciation and amortization expenses     29,265         5,847      1,249     36,361
     -----------------------------------------------------------------------------------------

             1997
             ----
     Net sales                                $457,109      $105,754    $19,086   $581,949
     Operating income                           43,989        16,296      2,959     63,244
     Assets                                    278,559        57,295     18,020    353,874
     Capital expenditures                       23,873         6,494      3,850     34,217
     Depreciation and amortization expenses     27,507         5,819        983     34,309
     -----------------------------------------------------------------------------------------
</TABLE>

                                      44
<PAGE>

Below are reconciliations of segment data to the accompanying consolidated
financial statements:

<TABLE>
<CAPTION>
(Dollars in thousands)                                   1999           1998          1997
- --------------------------------------------------------------------------------------------
<S>                                                    <C>           <C>           <C>
Operating income - segment totals                      $ 77,030      $  67,319     $  63,244
Unallocated corporate expenses/(a)/                     (35,252)       (21,896)      (18,874)
Interest expenses                                        (8,376)        (7,453)       (7,595)
Income /(Loss) from equity in joint ventures              1,427            796        (1,901)
- --------------------------------------------------------------------------------------------
     Consolidated income before income taxes           $ 34,829      $  38,766     $  34,874
============================================================================================

Assets - segment totals                                $386,774      $ 381,822     $ 353,874
Unallocated corporate assets/(b)/                        27,802         22,539        21,062
- --------------------------------------------------------------------------------------------
     Consolidated assets                               $414,576      $ 404,361     $ 374,936
============================================================================================

Capital expenditures - segment totals                  $ 30,076      $  42,375     $  34,217
Unallocated corporate expenditures                        2,621          1,681         1,372
- --------------------------------------------------------------------------------------------
     Consolidated capital expenditures                 $ 32,697      $  44,056     $  35,589
============================================================================================
Depreciation and amortization expenses - segment
 totals                                                $ 38,075      $  36,361     $  34,309
Unallocated corporate depreciation expenses               1,377            986           972
     Consolidated depreciation and
      amortization expenses                            $ 39,452      $  37,347     $  35,281
============================================================================================
</TABLE>

     (a)  Includes corporate administrative and corporate manufacturing expenses
          which are not included in segment operating income and not used to
          evaluate segment performance.
     (b)  Includes items such as deferred tax asset, prepaid pension asset,
          joint venture investments and LIFO inventory reserve which are not
          allocated to segments.

     Company-wide geographic data for the years ended December 31, 1999, 1998
     and 1997, is as follows (net sales attributed to countries based on selling
     location):

<TABLE>
<CAPTION>
(Dollars in thousands)                     1999          1998          1997
- -------------------------------------------------------------------------------
<S>                                     <C>            <C>           <C>
Net sales
  United States                         $ 532,174      $506,075      $494,496
  All foreign countries                   134,610       104,376        87,453
- -------------------------------------------------------------------------------
    Total                               $ 666,784      $610,451      $581,949
===============================================================================

Long-lived assets
  United States                         $ 193,436      $200,587      $192,821
  All foreign countries                    16,045        14,509        13,780
- -------------------------------------------------------------------------------
     Total                              $ 209,481      $215,096      $206,601
===============================================================================
</TABLE>

                                      45
<PAGE>

15.  Earnings Per Share


Below is the computation of basic and diluted earnings per share for the years
ended December 31, 1999, 1998 and 1997:

<TABLE>
<CAPTION>
(In thousands, except per share amounts)                     1999           1998          1997
- ------------------------------------------------------------------------------------------------
<S>                                                         <C>            <C>           <C>
Computation of Basic Earnings per Share
Net income                                                  $22,129        $23,454       $20,410
Deduct dividends on preferred stock                             858            896         1,027
- ------------------------------------------------------------------------------------------------
Income applicable to common stock                           $21,271        $22,558       $19,383

Weighted-average number of shares outstanding                 9,592          9,843         9,831

Basic earnings per share                                    $  2.22        $  2.29       $  1.97
- ------------------------------------------------------------------------------------------------

Computation of Diluted Earnings per Share
Net income                                                  $22,129        $23,454       $20,410

Weighted-average number of shares outstanding                 9,592          9,843         9,831
Add net shares from assumed exercise of options
  (under treasury stock method)                                 324            456           275
Add weighted-average shares from assumed
  conversion of convertible preferred stock                     716            744           853
- ------------------------------------------------------------------------------------------------
Shares applicable to diluted earnings                        10,632         11,043        10,959

Diluted earnings per share                                  $  2.08        $  2.12       $  1.86
- ------------------------------------------------------------------------------------------------
</TABLE>

                                      46
<PAGE>

                               Five Year Summary
              (In thousands, except per share and employee data)

<TABLE>
<CAPTION>
For the Year                                          1999           1998           1997           1996            1995
- -------------------------------------------------------------------------------------------------------------------------
<S>                                                <C>            <C>            <C>             <C>             <C>
Net Sales                                          $666,784       $610,451       $581,949        $536,635        $528,218
Operating Income                                     41,778         45,423         44,370          40,386          32,620
   Percent of net sales                                 6.3%           7.4%           7.6%            7.5%            6.2%
- -------------------------------------------------------------------------------------------------------------------------
Pre-tax Income                                       34,829         38,766         34,874          32,261          24,991
   Percent of net sales                                 5.2%           6.4%           6.0%            6.0%            4.7%
- -------------------------------------------------------------------------------------------------------------------------
Provision for Income Taxes                           12,700         15,312         14,464          13,194           8,872
- -------------------------------------------------------------------------------------------------------------------------
Net Income                                           22,129         23,454         20,410          19,067          16,119
   Per share (Diluted)/(a)/                            2.08           2.12           1.86            1.71            1.46
   Percent of net sales                                 3.3%           3.8%           3.5%            3.6%            3.1%
   Percent to stockholders' equity/(b)/                15.0%          17.0%          15.5%           15.6%           14.5%
- -------------------------------------------------------------------------------------------------------------------------
Cash Dividends Paid                                   6,727          6,432          6,069           5,846           5,540
   Per common share                                   .6125          .5625          .5125           .4775           .4475
- -------------------------------------------------------------------------------------------------------------------------
Depreciation and Amortization                        39,452         37,347         35,281          32,138          30,384
Capital Expenditures                                 32,697         44,056         35,589          44,923          39,247
Weighted-Average Common
Shares Outstanding                                    9,592          9,843          9,831          10,002           9,984
- -------------------------------------------------------------------------------------------------------------------------

As of Year End
- -------------------------------------------------------------------------------------------------------------------------
Working Capital                                    $ 68,615       $ 61,814       $ 63,789        $ 70,322        $ 66,856
Current Ratio                                           1.7            1.7            1.8             1.8             1.8
- -------------------------------------------------------------------------------------------------------------------------
Property, Plant and Equipment, net                  209,481        215,096        206,601         207,159         192,470
Total Assets                                        414,576        404,361        374,936         381,012         362,527
Long-term Debt, less current maturities             107,420        107,708         94,898         102,567         109,023
- -------------------------------------------------------------------------------------------------------------------------
Stockholders' Equity                                155,064        147,984        137,598         131,615         122,477
   Per share /(c)/                                    15.20          14.18          13.01           12.24           11.25
Number of Employees                                   1,365          1,372          1,292           1,270           1,267
=========================================================================================================================
</TABLE>

/(a)/  Based on weighted-average number of common shares outstanding during the
       year.
/(b)/  Based on equity at beginning of year.
/(c)/  Based on common shares and the assumed conversion of the convertible
       preferred shares outstanding at year end.

                                      47
<PAGE>

Quarterly Stock Data (Unaudited)

<TABLE>
<CAPTION>
                                                                                          Dividends Paid
                                             Stock Price Range                           Per Common Share
           -------------------------------------------------------------------------------------------------
                          1999                                        1998              1999         1998
           -------------------------------------------------------------------------------------------------
Quarter          High             Low              High              Low
- ----------------------------------------------------------------------------------
<S>          <C>     <C>      <C>     <C>       <C>     <C>        <C>      <C>         <C>         <C>
 First       $26     11/16    $22      1/4      $30     1/2        $26      1/8         15.00c       13.75c
 Second       25     11/16     22      1/4       32     1/4         29      5/8         15.00c       13.75c
 Third        26       1/4     22      5/8       31     1/4         23      1/8         15.00c       13.75c
 Fourth       24       1/8     22     3/16       29                 24      5/8         16.25c       15.00c
                                                                                      ----------------------
 Year         26     11/16     22     3/16       32     1/4         23      1/8         61.25c       56.25c
- ------------------------------------------------------------------------------------------------------------
</TABLE>

Quarterly Financial Data (Unaudited)
(Dollars in thousands, except per share data)

<TABLE>
<CAPTION>
                                                                   1999
                                   ------------------------------------------------------------------
Quarter                                 First        Second        Third       Fourth       Year
- -----------------------------------------------------------------------------------------------------
<S>                                <C>              <C>           <C>          <C>         <C>
Net Sales                             $163,961      $166,759      $166,932     $169,132    $666,784
- -----------------------------------------------------------------------------------------------------
Gross Profit                            28,919        32,391        28,249       31,386     120,945
- -----------------------------------------------------------------------------------------------------
Interest, net                           (2,110)       (2,158)       (2,052)      (2,056)     (8,376)
- -----------------------------------------------------------------------------------------------------
Pre-tax Income                          10,148        12,963            23       11,695      34,829
- -----------------------------------------------------------------------------------------------------
Net Income                               6,142         7,956            14        8,017      22,129
- -----------------------------------------------------------------------------------------------------
Net Income per Share (Diluted)             .57           .75          (.02)         .76        2.08
- -----------------------------------------------------------------------------------------------------
</TABLE>


<TABLE>
<CAPTION>

                                                                1998
                                   ------------------------------------------------------------------
Quarter                               First       Second        Third       Fourth        Year
- -----------------------------------------------------------------------------------------------------
<S>                                <C>          <C>           <C>         <C>           <C>
Net Sales                          $150,388     $155,509      154,134     $150,420      $610,451
- -----------------------------------------------------------------------------------------------------
Gross Profit                         27,829       29,654       25,827       28,285       111,595
- -----------------------------------------------------------------------------------------------------
Interest, net                        (1,907)      (1,769)      (1,853)      (1,924)       (7,453)
- -----------------------------------------------------------------------------------------------------
Pre-tax Income                        9,538       11,859        8,131        9,238        38,766
- -----------------------------------------------------------------------------------------------------
Net Income                            5,722        7,110        5,032        5,590        23,454
- -----------------------------------------------------------------------------------------------------
Net Income per Share (Diluted)          .52          .64          .45          .51          2.12
- -----------------------------------------------------------------------------------------------------
</TABLE>

                                      48

<PAGE>

                                                                    Exhibit (21)

                                STEPAN COMPANY
                          SUBSIDIARIES OF REGISTRANT



   Subsidiary                          Organized under the Laws of:
   ----------                          ----------------------------

   Stepan Europe S.A.                         France
   Stepan Canada, Inc.                        Canada
   Stepan Mexico, S.A. de C.V.                Mexico
   Stepan Deutschland GmbH                    Germany
   Stepan Colombiana de Quimicos              Colombia
   Stepan Quimica Ltda.                       Brazil

<PAGE>

                                                                    Exhibit (23)


                   CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

  As independent public accountants, we hereby consent to the incorporation of
our reports, included or incorporated by reference in this Form 10-K, into the
company's previously filed Registration Statements on Form S-8, File Nos. 2-
64668, 2-40183, 2-80336 and 33-57189.





                                                 ARTHUR ANDERSEN LLP

 Chicago, Illinois,
 March 30, 2000

<PAGE>

                                                                    Exhibit (24)


                               POWER OF ATTORNEY
                               -----------------

    The undersigned hereby appoints F. Quinn Stepan and Walter J. Klein and each
 of them individually, the true and lawful attorney or attorneys of the
 undersigned, with substitution and resubstitution, to execute in his name,
 place and stead in his capacity as an officer or director or both of Stepan
 Company, a Delaware corporation, the Annual Report of Form 10-K under the
 Securities Exchange Act of 1934, and any amendments or supplements thereto, and
 all instruments necessary or incidental in connection therewith, and to file or
 cause to be filed such Annual Report and related documents with the Securities
 and Exchange Commission.  Each of said attorneys shall have full power and
 authority to do and perform, in the name and on behalf of the undersigned,
 every act whatsoever necessary or desirable to be done in the premises, as
 fully as all intents and purposes of the undersigned could do in person.  The
 undersigned hereby ratifies and approves the actions of said attorneys and each
 of them.

    IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on
 this 10th day of March 2000


                                             /s/   F. Quinn Stepan
                                             -----------------------------------
                                             F. Quinn Stepan

                                             /s/   F. Quinn Stepan, Jr.
                                             -----------------------------------
                                             F. Quinn Stepan, Jr.

                                             /s/   Walter J. Klein
                                             -----------------------------------
                                             Walter J. Klein

                                             /s/   James A. Hartlage
                                             -----------------------------------
                                             James A. Hartlage

                                             /s/   Thomas F. Grojean
                                             -----------------------------------
                                             Thomas F. Grojean

                                             /s/   Paul H. Stepan
                                             -----------------------------------
                                             Paul H. Stepan

                                             /s/   Robert D. Cadieux
                                             -----------------------------------
                                             Robert D. Cadieux

                                             /s/   Robert G. Potter
                                             -----------------------------------
                                             Robert G. Potter

<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONSOLIDATED
BALANCE SHEET AS OF DECEMBER 31, 1999 AND CONSOLIDATED STATEMENT OF INCOME FOR
THE TWELVE MONTHS THEN ENDED AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                           3,969
<SECURITIES>                                         0
<RECEIVABLES>                                   99,478
<ALLOWANCES>                                     2,389
<INVENTORY>                                     51,849
<CURRENT-ASSETS>                               166,660
<PP&E>                                         596,904
<DEPRECIATION>                                 387,423
<TOTAL-ASSETS>                                 414,576
<CURRENT-LIABILITIES>                           98,045
<BONDS>                                              0
                                0
                                     19,575
<COMMON>                                         9,685
<OTHER-SE>                                     125,804
<TOTAL-LIABILITY-AND-EQUITY>                   414,576
<SALES>                                        666,784
<TOTAL-REVENUES>                               545,839
<CGS>                                          625,006
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                               666,784
<INTEREST-EXPENSE>                               8,376
<INCOME-PRETAX>                                 34,829
<INCOME-TAX>                                    12,700
<INCOME-CONTINUING>                             22,129
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    22,129
<EPS-BASIC>                                       2.22
<EPS-DILUTED>                                     2.08


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission